<!DOCTYPE html><html lang="en" class=" dark" style="--fv-scrollbar-width: 0px;"><script src="https://rules.quantcount.com/rules-p-c2W8esUZ6Q8oA.js" async=""></script><script type="text/javascript" async="" src="https://www.googletagmanager.com/gtag/js?id=G-ZT9VQEWD4N&amp;cx=c&amp;gtm=45je57o0h1v9119704755za200&amp;tag_exp=101509157~103116026~103200004~103233427~104684208~104684211"></script><script src="https://secure.quantserve.com/quant.js" async="" type="text/javascript"></script><script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-537M973G"></script><script id="IC_GTagScript" src="https://www.googletagmanager.com/gtag/js?id=G-5EST90M6PX" type="text/javascript" async=""></script><script id="IC_UAT_TAG_SCRIPT" src="https://u5.investingchannel.com/static/uat-tag.js" type="text/javascript" async=""></script><head>
<title>ABEO - Abeona Therapeutics Inc Stock Price and Quote</title>
<meta charset="UTF-8"><meta name="viewport" content="width=1024"><meta name="description" content="ABEO - Abeona Therapeutics Inc - Stock screener for investors and traders, financial visualizations.">

            <link rel="preload" href="/fonts/lato-v17-latin-ext_latin-regular.woff2" as="font" crossorigin="">
            <link rel="preload" href="/fonts/lato-v17-latin-ext_latin-700.woff2" as="font" crossorigin="">
            <link rel="preload" href="/fonts/lato-v17-latin-ext_latin-900.woff2" as="font" crossorigin="">
            <link rel="preload" href="/fonts/finviz-sans-415-normal-latin.woff2" as="font" crossorigin="">
            <link rel="preload" href="/fonts/finviz-sans-450-normal-latin.woff2" as="font" crossorigin="">
            <link rel="preload" href="/fonts/finviz-sans-500-normal-latin.woff2" as="font" crossorigin="">
            <link rel="preload" href="/fonts/finviz-sans-700-normal-latin.woff2" as="font" crossorigin="">
        
            <script async="" src="https://urbanlaurel.com/assets/js/q2o3um29vhadcznq.vendor.js"></script><script>
                window.notificationsArray = [];
                window.renderScriptNotLoaded = function () {};
                window.handleScriptNotLoaded = function (element) {
                    window.notificationsArray.push(element);
                    window.sentryDisabled = true;
                    window.handleScriptNotLoaded = function () {};
                };
            </script>
        <link rel="stylesheet" href="/assets/dist/redesign.c1b68a69.css" type="text/css" onerror="window.handleScriptNotLoaded(this)">
<link rel="stylesheet" href="/assets/dist/main.f6c954db.css" type="text/css" onerror="window.handleScriptNotLoaded(this)">
<link rel="icon" type="image/png" href="/favicon_2x.png" sizes="32x32">
<link rel="icon" type="image/png" href="/favicon.png" sizes="16x16">
<link rel="canonical" href="/quote.ashx?t=ABEO">
<script async="true">
    !(function(q,_name){q[_name]=q[_name]||function k(){(k.q=k.q||[]).push(arguments)},q[_name].v=q[_name].v||2,q[_name].s="1";!(function(q,k,F,H){function m(F,H){try{m=q.localStorage,(F=JSON.parse(m[decodeURI(decodeURI('%67%25%365%25%37%34I%257%34e%6d'))]("_aQS01OUU2MkU1RURCQzRDMzUyMTIwQkM4ODYtMTE0")).lgk||[])&&(H=q[k].pubads())&&F.forEach((function(q){q&&q[0]&&H.setTargeting(q[0],q[1]||"")}))}catch(N){}var m}try{(H=q[k]=q[k]||{}).cmd=H.cmd||[],typeof H.pubads===F?m():typeof H.cmd.unshift===F?H.cmd.unshift(m):H.cmd.push(m)}catch(N){}})(window,decodeURI(decodeURI('%25%367o%25%36fg%256c%25%36%35%2574%256%31%25%36%37')),"function");;!(function(q){q.__admiral_getConsentForGTM=function(k){function F(q,F){k((function(q,k){const F=q&&q.purpose&&q.purpose.consents||{};return{adConsentGranted:k||!!F[1],adUserData:k||!!F[7],adPersonalization:k||!!F[3],analyticsConsentGranted:k||!!F[1],personalizationConsentGranted:k||!!F[5],functionalityConsentGranted:k||!1,securityConsentGranted:k||!0}})(q,!F))}q[_name]("after","cmp.loaded",(function(k){k&&k.tcData&&k.tcData.gdprApplies?(k.consentKnown&&F(k.tcData,!0),q[_name]("after","cmp.updated",(function(q){F(q.tcData,!0)}))):F({},!1)}))}})(window);})(window,decodeURI(decodeURI('a%256%34m%25%369%25%37%32%256%31l')));!(function(q,k,F,H){F=q.createElement(k),q=q.getElementsByTagName(k)[0],F.async=1,F.src="https://urbanlaurel.com/assets/js/q2o3um29vhadcznq.vendor.js",(H=0)&&H(F),q.parentNode.insertBefore(F,q)})(document,"script");;;!(function(q,k,F,H,m){function N(){for(var q=[],F=0;F<arguments.length;F++)q.push(arguments[F]);if(!q.length)return m;"ping"===q[0]?q[2]({gdprAppliesGlobally:!!k[decodeURI(decodeURI('_%25%35%66c%6d%25%37%30%254%37%25%364%25%370%257%32A%2570%25%370%256%63%2569%65%73%2547%256%63o%25%36%32%25%361%25%36%63%6c%79'))],cmpLoaded:!1,cmpStatus:"stub"}):q.length>0&&m.push(q)}function L(q){if(q&&q.data&&q.source){var H,m=q.source,N="__tcfapiCall",L="string"==typeof q.data&&q.data.indexOf(N)>=0;(H=L?((function(q){try{return JSON.parse(q)}catch(k){}})(q.data)||{})[N]:(q.data||{})[N])&&k[F](H.command,H.version,(function(q,k){var F={__tcfapiReturn:{returnValue:q,success:k,callId:H.callId}};m&&m.postMessage(L?JSON.stringify(F):F,"*")}),H.parameter)}}!(function t(){if(!k.frames[H]){var F=q.body;if(F){var m=q.createElement("iframe");m.style.display="none",m.name=H,F.appendChild(m)}else setTimeout(t,5)}})(),N.v=1,"function"!=typeof k[F]&&(k[F]=k[F]||N,k.addEventListener?k.addEventListener("message",L,!1):k.attachEvent&&k.attachEvent("onmessage",L))})(document,window,"__tcfapi","__tcfapiLocator",[]);;;!(function(q,k,F,H,m,N,L,t,A,K,R){function Y(){for(var q=[],k=arguments.length,F=0;F<k;F++)q.push(arguments[F]);var H,m=q[1],N=typeof m===L,t=q[2],Y={gppVersion:"1.1",cmpStatus:"stub",cmpDisplayStatus:"hidden",signalStatus:"not ready",supportedAPIs:["7:usnat"].reduce((function(q,k){return k&&q.push(k),q}),[]),cmpId:9,sectionList:[],applicableSections:[0],gppString:"",parsedSections:{}};function v(q){N&&m(q,!0)}switch(q[0]){case"ping":return v(Y);case"queue":return A;case"events":return K;case"addEventListener":return N&&(H=++R,K.push({id:H,callback:m,parameter:t})),v({eventName:"listenerRegistered",listenerId:H,data:!0,pingData:Y});case"removeEventListener":for(H=!1,F=0;F<K.length;F++)if(K[F].id===t){K.splice(F,1),H=!0;break}return v(H);case"hasSection":case"getSection":case"getField":return v(null);default:return void A.push(q)}}Y.v=2,typeof k[F]!==L&&(k[F]=k[F]||Y,k[t]&&k[t]("message",(function(q,H){var L="string"==typeof q.data;(H=L?((function(q){try{return JSON.parse(q)}catch(k){}})(q.data)||{})[m]:(q.data||{})[m])&&k[F](H.command,(function(k,F){var m={__gppReturn:{returnValue:k,success:F,callId:H.callId}};q.source.postMessage(L?JSON.stringify(m):m,"*")}),N in H?H[N]:null,H.version||1)}),!1),(function v(){if(!k.frames[H]){var F=q.body;if(F){var m=q.createElement("iframe");m.style.display="none",m.name=H,F.appendChild(m)}else setTimeout(v,5)}})())})(document,window,"__gpp","__gppLocator","__gppCall","parameter","function","addEventListener",[],[],0);
    ;(function () {
        window.ic_privacySelectorLoaded = false;

        window.admiral("after", "candidate.dismissed", function () {
            if (window.checkBannersLoaded) checkBannersLoaded();
        });

        window.admiral("after", "cmp.loaded", function (eventArg) {
            console.log("Admiral CMP Loaded ", eventArg);
            if (eventArg.euVisitor) return;
            try {
                __gpp("addEventListener", function (tcData) {
                    window.ic_privacySelectorLoaded = true;
                });
            } catch (e) {
                console.error(e)
            }
        });
    })();
</script><script>
            FinvizSettings = {
                versionImages: 26,
                hasUserPremium: false,
                name: "",
                email: "",
                nodeChartsDomain: "https://charts2-node.finviz.com",
                hasUserStickyHeader: false,
                adsProvider: 1,
                hasRedesignEnabled: true,
                hasRedesignPortfolio: false,
                hasDarkTheme: true,
                quoteSearchExt: '',
                isJoinBannerVisible: false,
                hasKnowledgeBase: false,
            };
        </script><script src="/assets/dist/script/browser_check.7d9dede5.js"></script><script src="/assets/dist/script/notice.b7d78fe4.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/script/vendor/boxover.202b25a7.js" defer=""></script>
<script src="/assets/dist/runtime.bc1bfc34.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/libs_init.0ef6a157.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/1150.122fda62.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/7470.8715c862.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/1545.f2265a6f.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/5747.e0a24ab5.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/1213.58b9b5ca.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/4841.f74a7ed9.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/5762.39085d07.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/header.d5ff61b3.js" onerror="window.handleScriptNotLoaded(this)"></script><link rel="preload" as="script" href="/assets/dist/2332.324a7c2b.js" data-chunk-id="quote-portal-components"><link rel="preload" as="script" href="/assets/dist/7833.6e630805.js" data-chunk-id="quote-portal-components"><link rel="preload" as="script" href="/assets/dist/9527.4bef4d82.js" data-chunk-id="quote-portal-components"><link rel="preload" as="script" href="/assets/dist/6195.a4563012.js" data-chunk-id="quote-portal-components"><link rel="preload" as="script" href="/assets/dist/9240.02d4eda3.js" data-chunk-id="quote-portal-components"><link rel="preload" as="script" href="/assets/dist/3160.d7333169.js" data-chunk-id="quote-portal-components"><link rel="preload" as="script" href="/assets/dist/9691.4193f4bc.js" data-chunk-id="quote-portal-components"><link rel="preload" as="script" href="/assets/dist/8733.fd779d5d.js" data-chunk-id="quote-portal-components"><link rel="preload" as="script" href="/assets/dist/5064.890c6304.js" data-chunk-id="quote-portal-components"><link rel="preload" as="script" href="/assets/dist/quote-portal-components.f2f9682b.js" data-chunk-id="quote-portal-components"><link rel="stylesheet" href="/assets/dist/charts_layout.70be5beb.css" onerror="window.handleScriptNotLoaded(this)"><script>
            const channelIdToLabel = {
                '1': 'MarketWatch',
                '2': 'WSJ',
                '3': 'Reuters',
                '4': 'Yahoo Finance',
                '5': 'CNN',
                '6': 'The New York Times',
                '7': 'Bloomberg',
                '9': 'BBC',
                '10': 'CNBC',
                '11': 'Fox Business',
                '102': 'Mish\'s Global Economic Trend Analysis',
                '105': 'Trader Feed',
                '113': 'Howard Lindzon',
                '114': 'Seeking Alpha',
                '123': 'Fallond Stock Picks',
                '132': 'Zero Hedge',
                '133': 'market folly',
                '136': 'Daily Reckoning',
                '141': 'Abnormal Returns',
                '142': 'Calculated Risk',
            }
            function trackAndOpenNews(event, channel, url) {
              event.preventDefault()
              window.open(url, '_blank')

              let channelLabel
              if (typeof channel === 'string') {
                const isInternalNewsUrl = url.startsWith('/news/')
                channelLabel = isInternalNewsUrl ? 'internal-' + channel : channel
              } else {
                const label = channelIdToLabel[channel]
                channelLabel = label !== undefined ? label : channel
              }
              window.gtag && window.gtag('event', 'click', {
                send_to: 'G-ZT9VQEWD4N',
                non_interaction: true,
                event_category: 'news',
                event_label: channelLabel,
                value: 1 });
            }
          </script><script type="text/javascript" async="" src="https://u5.investingchannel.com/static/uat.js"></script><link href="https://u5.investingchannel.com/prebid/8.24.0/prebid.js" rel="preload" as="script"><link href="https://u5.investingchannel.com/static/uat-internal.js" rel="preload" as="script"><link href="https://u5.investingchannel.com/static/uat-tag.js" rel="preload" as="script"><link rel="preconnect" href="https://static.adsafeprotected.com"><script src="https://u5.investingchannel.com/uat/static/icayapi.js" id="AYUatKeyValues" async="true"></script><script src="https://investingchannel.ay.delivery/manager/vrTNGjbrtn4XaEtGa" id="TagManager" referrerpolicy="no-referrer-when-downgrade"></script></head>

          
          <body class="m-0 yellow-tooltip is-quote min-w-[1009px] chart-tooltip table w-full">
            <script>
                window.adLayoutVersion = 'control';
                window.adLoggedIn = 'NotLoggedIn';

                var cookieName = 'fv_block';
                var selector = '[data-google-query-id]';
                var selectorFrame = selector + ' iframe, ' + selector + ' [id*=aax]';
                var cookieExpiry = 5 * 60 * 1000; // 5min
                var checkTimeout = 20 * 1000; // 20sec

                function getCookie(value) {
                    var expiration = +new Date() + cookieExpiry;
                    return cookieName + '=' + value + '; expires=' + (new Date(expiration)).toUTCString() + '; path=/';
                }

                var finvizBannersLoaded = false;
                function loadFinvizBanners(setCookie) {
                    
                    if (setCookie) document.cookie = getCookie('block');
                    finvizBannersLoaded = true;
                    var s = document.createElement('script');
                    s.type = 'text/javascript';
                    s.async = true;
                    s.src = '/assets/dist/script/finviz_b.d6c84ef3.js';
                    document.head.appendChild(s);
                }

                function checkBannersLoaded() {
                    var checkEnd = +new Date() + checkTimeout;
                    function asyncCheckIfExists(selector, resolve) {
                        var now = +new Date();
                        var container = document.querySelector(selector);
                        if (!container && checkEnd > now) return setTimeout(function () { asyncCheckIfExists(selector, resolve) }, 1000)
                        resolve(!!container);
                    }

                    asyncCheckIfExists(selector, function (exists) {
                        if (!exists) return loadFinvizBanners(true);

                        asyncCheckIfExists(selectorFrame, function (hasIframe) {
                            if (!hasIframe) return loadFinvizBanners(true);
                        })
                    })
                }

                if (document.cookie.indexOf(cookieName) >= 0) {
                    loadFinvizBanners(false);
                } else {
                    var s = document.createElement('script');
                    s.type = 'text/javascript';
                    s.async = true;
                    s.onerror = loadFinvizBanners;
                    s.src = 'https://u5.investingchannel.com/static/uat.js';
                    document.head.appendChild(s);

                    InvestingChannelQueue = window.InvestingChannelQueue || [];
                    var ic_page;

                    function refreshAd(container, refreshes) {
                        var placementTag, adslot;
                        window.InvestingChannelQueue.push(function () {
                            var pubTags = ic_page.getPubTag.call(ic_page, container.id);
                            if (!pubTags) return;
                            var pubTag = pubTags[0];
                            placementTag = pubTag.mPlacements[0].mTagToRender;
                            adslot = pubTag.mPlacements[0].mPublisherKval.adslot[0];
                            // Update div ID
                            var id = container.id.split('_');
                            var numberOfDivs = document.querySelectorAll('[id*=' + id.slice(0, id.length - 1).join('_') + ']').length;
                            var newDivNumber = Number(id.pop()) + numberOfDivs * refreshes;
                            container.setAttribute('id', id.join('_') + '_' + newDivNumber);
                            // Destroy previous pubtag & reset container html (loading span)
                            pubTag.destroy();
                            container.innerHTML = '';
                        });
                        window.InvestingChannelQueue.push(function () {
                            if (!placementTag || !adslot) return
                            // Create new pub tag
                            var newTag;
                            var layoutId = placementTag.mNativeLayout ? placementTag.mNativeLayout.nativelayoutid : null;
                            if (layoutId) {
                                newTag = ic_page.defineNativeTag('finviz/' + placementTag.mTarget.dfpkeyname, placementTag.mAdSize, container.id, layoutId);
                                var nativeLayout, layoutData

                                try {
                                  nativeLayout = newTag.mPlacements[0].mTags[0].mNativeLayout;
                                } catch (e) {
                                    console.log(e.message)
                                }

                                try {
                                  layoutData = newTag.mTemplate.mNativeLayout[layoutId].Data
                                  if (layoutData && nativeLayout && !nativeLayout.layout) {
                                    newTag.mPlacements[0].mTags[0].mNativeLayout = layoutData
                                  }
                                } catch (e) {
                                    console.log(e.message)
                                }
                            } else {
                                newTag = ic_page.defineTag('finviz/' + placementTag.mTarget.dfpkeyname, placementTag.mAdSize, container.id);
                            }
                            // Set adslot param
                            newTag.setKval({ adslot: adslot });
                            newTag.setKval({ kw: 'ajax' });
                            newTag.render();
                        });
                    }

                    var refreshCount = 1;
                    function refreshAds(selectors) {
                        if (window.ic_page) {
                            document.querySelectorAll(selectors).forEach(function (element) {
                                try {
                                    refreshAd(element, refreshCount);
                                } catch (e) {
                                    console.log('Ad refresh error for:', element, e);
                                }
                            });
                            window.ic_page.loadMore();
                            refreshCount++;
                        }
                    }


                    InvestingChannelQueue.push(function() {
                        var icConfig = window['FINVIZ_IC_UAT_CONFIG'] = {};
                        
                        ic_page = InvestingChannel.UAT.Run('df0d0d52-cc7f-11e8-82a5-0abbb61c4a6a', icConfig);
                    });

                    var hash = null;
                    if (typeof hash === 'string') {
                      InvestingChannelQueue.push(function() {
                          if (ic_page) {
                              ic_page.setUserId('email', hash, true);
                          }
                      });
                    }
                }
            </script>
            <script>
                (function () {
                    var detectionEl = document.createElement('div');
                    detectionEl.style.position='absolute';
                    detectionEl.style.overflow='scroll';
                    document.body.appendChild(detectionEl);
                    document.documentElement.style.setProperty('--fv-scrollbar-width', `${detectionEl.offsetWidth}px`);
                    document.body.removeChild(detectionEl);
                })()
            </script>
        <div id="notifications-container"></div><table class="header">
    <tbody><tr class="align-top">
        <td>
            <table class="header-container">
                <tbody><tr>
                    <td class="w-[30%]">
                        <table class="w-full">
                            <tbody><tr>
                                <td class="h-[50px] align-middle">
                                    <a href="/" class="logo"><svg width="225" height="32" class="block">
  <use href="/img/logo.svg#free" class="dark:hidden"></use>
  <use href="/img/logo.svg#free-dark" class="hidden dark:block"></use>
</svg></a>
                                </td>
                            </tr>
                            <tr>
                                <td id="search" style="padding-top: 7px"><div class="w-full"><label class="flex grow flex-col"><div class="group relative flex"><span class="pointer-events-none top-0 h-full flex absolute w-3 items-center justify-center left-2.5"><svg class="pointer-events-none block shrink-0 fill-current text-gray-500" width="1rem" height="1rem"><use href="/assets/dist-icons/icons.svg?rev=26#search"></use></svg></span><input autocomplete="off" autocorrect="off" autocapitalize="off" maxlength="100" placeholder="Search ticker, company or profile" enterkeyhint="go" aria-label="Search" data-autofocus="true" id="«r1»" role="combobox" aria-autocomplete="list" aria-haspopup="listbox" aria-expanded="false" data-active-item="true" class="border bg-transparent disabled:border-gray-700 disabled:bg-gray-700 disabled:text-gray-400 border-gray-100 dark:border-gray-600 text-gray-750 dark:text-gray-50 h-8 text-sm rounded-md max-w-95 w-full grow select-text appearance-none outline-none mobile:h-8 mobile:text-base px-2.5 pl-7.5" value="" data-focus-visible="true"></div></label></div></td>
                            </tr>
                        </tbody></table>
                    </td>
                    <td class="align-bottom pb-1">
                        <div id="microbar_position" class="hidden xl:flex items-center h-[37px] pl-2"><div>
                        <div id="IC_D_88x31_1" class="relative overflow-hidden flex items-center justify-center w-full mx-auto" style="width:88px;height:31px;max-height:31px"></div>
                        </div></div>
                    </td>
                    <td class="relative w-[730px] text-right">
                        <div id="banner_position" class="overflow-hidden absolute top-0 right-0 w-full h-[96px]">
                        <div id="IC_D_728x90_1" class="relative overflow-hidden flex items-center justify-center w-full mx-auto" style="width:728px;height:90px;max-height:90px"></div>
                        </div>
                    </td>
                </tr>
            </tbody></table>
        </td>
    </tr>
    <tr>
        <td class="w-[994px] leading-none" style="font-size:0">
            <img src="/gfx/nic2x2.gif" class="w-[994px] h-px" alt="" width="2" height="2">
        </td>
    </tr>
</tbody></table>
            <table class="navbar">
                <tbody><tr>
                    <td class="h-[30px]">
                        <table class="header-container">
                            <tbody><tr><td><a class="nav-link is-first" href="/">Home</a></td><td><a class="nav-link" href="/news.ashx">News</a></td><td><a class="nav-link" href="/screener.ashx">Screener</a></td><td><a class="nav-link" href="/map.ashx">Maps</a></td><td><a class="nav-link" href="/groups.ashx">Groups</a></td><td><a class="nav-link" href="/portfolio.ashx">Portfolio</a></td><td><a class="nav-link" href="/insidertrading.ashx">Insider</a></td><td><a class="nav-link" href="/futures.ashx">Futures</a></td><td><a class="nav-link" href="/forex.ashx">Forex</a></td><td><a class="nav-link" href="/crypto.ashx">Crypto</a></td><td><a class="nav-link" href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=main-navbar-backtests">Backtests</a></td><td><a class="nav-link is-elite" href="/elite">Pricing</a></td><td class="w-full relative"><div class="absolute bottom-0 left-0 right-0 top-0"><div id="time" class="pr-1"><div class="w-full text-info text-white"><div class="flex items-center justify-end overflow-hidden whitespace-nowrap"><span>12:34 PM</span></div></div></div></div></td>
                    <td class="nav relative">
        <a data-testid="chart-layout-theme" href="#" class="!flex !bg-transparent !border-b-0 mt-1 !py-0 !px-1" style="border-left: 1px solid #444a57" title="Toggle Light/Dark mode" onclick="setChartThemeCookie('light', true)">
            <div class="relative box-content flex rounded-full w-10 h-5 border border-gray-750 bg-gray-800 text-white justify-end">
                <div class="box-border w-1/2 rounded-full p-px border border-gray-800 bg-[#4c5261] flex justify-center items-center">
                    <svg width="16" height="16" class="fill-current text-white inline-block -ml-px">
    <use href="/assets/dist-icons/icons.svg?rev=26#moonOutlined"></use>
</svg>
                </div>
            </div>
            <span class="ml-1 select-none font-medium text-xs text-white">Theme</span>
        </a>
    </td>
    
                <td>
                    <a href="/help/screener.ashx" class="nav-link is-help border-l border-[#444a57]"><span class="fa fa-question-circle"></span>Help</a>
                </td>
                <td><a href="/login" class="nav-link sign-in">Login</a></td>
                <td><a href="/register" class="nav-link sign-up">Register</a></td>
            
                            </tr>
                        </tbody></table>
                    </td>
                </tr>
            </tbody></table>
        
          <script>
            function reloadPage () { location.reload() }
            function setChartThemeCookie(chartsTheme) {
              fetch('/api/set_cookie.ashx?cookie=chartsTheme&value=' + chartsTheme ).catch(function(){}).then(function(){
                window.gtag && window.gtag('event', 'click', { event_category: 'theme', event_label: 'toggle', value: chartsTheme, event_callback: reloadPage });
                setTimeout(reloadPage,1000);
              })
            }
          </script>    <div class="w-full flex justify-center dark:bg-violet-800 bg-violet-600 font-sans" data-fv-notice="promo-crypto" data-nosnippet="">
        <div class="h-10 relative flex gap-2.5 items-center dark:text-violet-200 text-white">
            <div class="py-3 text-sm font-medium dark:text-violet-200 text-violet-100">
                    <p>
        <span class="text-white">New:</span>
        Introducing the Finviz Crypto Map
    </p>
            </div>
            <a title="Learn more" href="/blog/introducing-the-finviz-crypto-map" class="inline-flex items-center justify-center rounded-md border-none outline-none ring-gray-200 font-medium focus-visible:ring-2 dark:ring-gray-500 bg-violet-500 hover:bg-gray-200/50 dark:bg-gray-500/30 dark:text-gray-50 text-white dark:hover:bg-gray-500/50 h-7 min-w-8 px-2.5 text-2xs" onclick="window.FinvizCloseNoticeRedirect(event, 'promo-crypto', this.href)">Learn More</a>
            <a title="Close" class="flex h-6 w-6 items-center justify-center" style="filter: drop-shadow(0.5px 0.5px 0px rgba(34, 38, 47, 0.8));" href="javascript:void(0)" onclick="window.FinvizCloseNotice('promo-crypto');">
                <svg width="20" height="20" class="shrink-0">
    <use href="/assets/dist-icons/icons.svg?rev=26#clear"></use>
</svg>
            </a>
        </div>
    </div><div class="content "><div class="ticker-wrapper gradient-fade" data-ticker="ABEO">
<div class="js-ticker-header-container bg-secondary sticky sticky-0 z-sticky bg-opacity-80 backdrop-blur-md"><div class="fv-container py-2.5 has-responsive-padding">    <div class="quote-header-wrapper">
        <div class="quote-header">
            <div class="quote-header_left">
                
                <div class="quote-header_ticker-wrapper">
                    <h1 class="js-recent-quote-ticker quote-header_ticker-wrapper_ticker" data-ticker="ABEO">ABEO</h1>
                    <h2 class="quote-header_ticker-wrapper_company text-xl">
                        <a class="tab-link block truncate" href="http://www.abeonatherapeutics.com" target="_blank" rel="nofollow">
                        Abeona Therapeutics Inc
                        </a>
                    </h2>
                </div>
            </div>
                <div class="quote-header_right js-quote-price-static">
            <div class="quote-price">
        <div class="sr-only">Last Close</div>
        <span class="quote-price_date">Jul 28 <span class="text-muted-3">•</span> 12:19PM ET</span>
        <div class="quote-price_wrapper">
            <strong class="quote-price_wrapper_price">6.64</strong>
                <table class="quote-price_wrapper_change text-positive">
                <tbody><tr>
                    <td>
                        <div class="sr-only">Dollar change</div>
                        +0.11
                    </td>
                    <td class="align-top"><svg width="12" height="12" class="fill-current">
    <use href="/assets/dist-icons/icons.svg?rev=26#arrowUpShort"></use>
</svg></td>
                </tr>
                <tr>
                    <td>
                        <div class="sr-only">Percentage change</div>
                        1.76
                    </td>
                    <td class="font-normal">%</td>
                </tr>
            </tbody></table>
        </div>
    </div>
        
    </div>
            <div class="js-quote-price-root quote-header_right hidden"></div>
        </div>
        <div class="quote-links whitespace-nowrap gap-8">
            <div class="flex space-x-0.5 overflow-hidden">
                <a href="screener.ashx?v=111&amp;f=sec_healthcare" class="tab-link">Healthcare</a>
                <span class="text-muted-3">•</span>
                <a href="screener.ashx?v=111&amp;f=ind_biotechnology" class="tab-link truncate" title="Biotechnology">Biotechnology</a>
                <span class="text-muted-3">•</span>
                <a href="screener.ashx?v=111&amp;f=geo_usa" class="tab-link">USA</a>
                <span class="text-muted-3">•</span>
                <a href="screener.ashx?v=111&amp;f=exch_nasd" class="tab-link">NASD</a>
            </div>
            <div>
                <div class="js-quote-navigation-static flex space-x-0.5 shrink-0">
                    <a href="/quote.ashx?t=ABEO&amp;ta=1&amp;p=d" class="tab-link font-semibold">
                        <span class="xl:hidden">Chart</span>
                        <span class="hidden xl:inline">Stock Detail</span>
                    </a>
                    <span class="text-muted-3">•</span>
                    <a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-compare-perf" class="tab-link" data-testid="quote-compare-perf-link-static">
                        <span class="xl:hidden">Compare</span>
                        <span class="hidden xl:inline">Compare Perf.</span>
                    </a>
                        <span class="text-muted-3">•</span>
    <a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=si" class="tab-link">Short Interest</a>
                    <span class="text-muted-3">•</span>
                    <a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=ea" class="tab-link">Financials</a>
                    <span class="text-muted-3">•</span>
                    <a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=tr" class="tab-link">Traffic</a>
                    <span class="text-muted-3">•</span>
                    <a data-testid="options-chain-link-static" href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=oc" class="tab-link">Options</a>
                    <span class="text-muted-3">•</span>
                    <a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=lf" class="tab-link">
                        <span class="xl:hidden">Filings</span>
                        <span class="hidden xl:inline">Latest Filings</span>
                    </a>
                    <span class="text-muted-3">•</span>
                    <a href="/save_to_portfolio.ashx?t=ABEO" class="tab-link">Add to Portfolio</a>
                    <span class="text-muted-3">•</span>
                    <a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-create-alert" class="tab-link">Set Alert</a>
                </div>
                <div class="js-quote-navigation-root hidden flex space-x-0.5 shrink-0 whitespace-nowrap" data-shortinterest="true" data-isfund="false"></div>
            </div>
        </div>
    </div></div></div><div id="root"></div>
<script>
            FinvizSettings.TA = {"style":"candlestick","overlays":[{"name":"sma","parameters":"20","color":"rgba(220,  50, 179, 0.39)"},{"name":"sma","parameters":"50","color":"rgba(255, 143,  51, 0.78)"},{"name":"sma","parameters":"200","color":"rgba(220, 179,  50, 0.43)"},{"name":"patterns","parameters":"","color":"rgba(135, 206, 239, 1)|rgba(220, 159, 229, 1)"}],"indicators":[]};
            window.FinvizQuoteTypeCurrent = FinvizSettings.TA.style;
        </script><div class="flex flex-col items-center min-w-[1009px]">
            <div id="app" class="interactive-chart" style="min-height: 462px;">
                <div id="chart" style="opacity: 0;min-width: 990px; position: relative"></div>
            </div>
            <div id="js-charts-modal"><div class="overlay modal hidden has-footer"></div></div>
            <div class="context-menu hidden"></div>
            <script type="text/javascript">
                    window.globalChartConfig = {
          "layout":"1h1v",
          "height": 400,
          "scrollable": true,
          "colors": undefined,
          "ideas": true,
          "editable": false,
          "editors": ['tools', 'ideas', 'publish', 'timeframe', 'settings'],
          "charts":[{
                "height": 400,
                "timeframe": "d",
                "dateRange": "",
                "scale": "linear",
                "ticker": "ABEO",
                "instrument": "stock",
                "refreshData": true,
                "premarket": 0,
                "aftermarket": 0,
                "hasChartEvents": true,
                "panes": []
              }],
        };
                    FinvizSettings.TA.style = 'candlestick';
                    window.FinvizQuoteTypeCurrent = FinvizSettings.TA.style;
                </script><script>
                        var data = {"ticker":"ABEO","timeframe":"d","volume":[77468,47528,42309,66220,38541,28914,130900,80135,36978,77802,76123,156695,102781,129181,124737,128873,73476,75004,32085,48994,66148,1586086,331077,313789,173004,147997,408695,171816,108768,279454,111176,85335,71850,103591,148583,241914,74795,208345,70480,99261,279891,1063995,576542,157780,144981,284088,280885,238877,174022,249029,203413,257862,171016,140295,152843,71698,138800,79177,153618,168143,95881,68000,112842,65620,547460,1057456,455727,160654,94803,126646,459378,377279,832805,497361,508228,406506,232872,314348,477041,212835,241434,242904,638725,623209,331010,251125,1160072,498179,484587,408208,425709,262604,405175,478884,251951,212713,463083,1397787,830333,370904,316808,171596,167610,198622,131092,267314,209474,229792,230312,173255,218316,209729,128401,160761,173527,188039,113688,218567,729644,245982,386264,1028038,5512776,2219367,1104119,1210920,2099991,2229204,1219256,756539,2685579,2437995,876150,455901,526684,1086831,534292,955320,1101517,501072,523022,474324,602870,343918,515412,540587,461699,380753,832256,443061,782773,405570,497901,369326,240352,466054,584275,423054,558768,232258,324532,799359,213565,1648060,270954,382695,221280,177635,243888,120193,160043,199723,367944,458280,639582,310319,515646,631060,475248,495532,543544,1096190,249140,170307,263896,157432,402094,241065,387036,319340,355560,284559,330259,489648,232901,199548,204781,427199,600505,208268,412797,345166,161187,286356,307313,198023,175648,399200,342103,189677,203753,239560,180068,230983,147875,201532,193194,156602,81799,86112,105517,151024,167332,181054,160408,516828,439419,309798,180910,306381,203047,330777,402693,499139,302273,204360,184583,428715,178597,224024,375544,207300,215813,143008,234671,197655,82011,81264,107133,205225,208786,163088,224453,500634,243311,253506,219108,433523,193105,183774,171260,195082,451515,925388,289140,411840,384585,737079,251941,215836,306554,387598,192484,212732,720326,165077,187409,229503,189543,212552,150691,163247,154056,188343,158374,131495,218509,154162,337542,219207,210374,163104,70352,128864,121971,217624,203401,392956,292903,312428,155303,176742,361769,267133,676389,375899,183826,170213,406442,185524,278069,405552,477608,316583,178742,205229,237491,217640,352451,238034,266672,284490,156819,185518,371526,339462,352888,358329,144886,180085,168592,323530,428100,279253,209137,181573,218148,387439,625448,454934,560707,406786,484592,313501,277261,287938,241665,337157,246613,1274265,571278,455647,511829,405309,412873,529407,868421,959517,1238202,996590,745836,876446,984522,1419555,674089,1017486,1114569,1140636,692187,822763,1207650,1261644,1611692,1351632,1045259,2163400,14907321,18507616,3448060,1794620,2171042,2312292,1691639,1408212,1151266,3720673,2079525,1642727,2007790,1396297,1197174,1280540,2665714,898595,957625,1547155,813521,1621524,1000654,1010410,907832,1119014,673882,940100,1065355,754627,798199,547963,373885,683644,718865,422011,1209254,778127,1116789,1278737,874554,7019858,955558,1011376,1379286,372932,750709,614275,974418,601704,774309,823540,593765,1036202,910487,721094,739262,472113,701066,527282,453034,202459],"date":[1698325200,1698411600,1698670800,1698757200,1698843600,1698930000,1699016400,1699279200,1699365600,1699452000,1699538400,1699624800,1699884000,1699970400,1700056800,1700143200,1700229600,1700488800,1700575200,1700661600,1700834400,1701093600,1701180000,1701266400,1701352800,1701439200,1701698400,1701784800,1701871200,1701957600,1702044000,1702303200,1702389600,1702476000,1702562400,1702648800,1702908000,1702994400,1703080800,1703167200,1703253600,1703599200,1703685600,1703772000,1703858400,1704204000,1704290400,1704376800,1704463200,1704722400,1704808800,1704895200,1704981600,1705068000,1705413600,1705500000,1705586400,1705672800,1705932000,1706018400,1706104800,1706191200,1706277600,1706536800,1706623200,1706709600,1706796000,1706882400,1707141600,1707228000,1707314400,1707400800,1707487200,1707746400,1707832800,1707919200,1708005600,1708092000,1708437600,1708524000,1708610400,1708696800,1708956000,1709042400,1709128800,1709215200,1709301600,1709560800,1709647200,1709733600,1709820000,1709906400,1710162000,1710248400,1710334800,1710421200,1710507600,1710766800,1710853200,1710939600,1711026000,1711112400,1711371600,1711458000,1711544400,1711630800,1711976400,1712062800,1712149200,1712235600,1712322000,1712581200,1712667600,1712754000,1712840400,1712926800,1713186000,1713272400,1713358800,1713445200,1713531600,1713790800,1713877200,1713963600,1714050000,1714136400,1714395600,1714482000,1714568400,1714654800,1714741200,1715000400,1715086800,1715173200,1715259600,1715346000,1715605200,1715691600,1715778000,1715864400,1715950800,1716210000,1716296400,1716382800,1716469200,1716555600,1716901200,1716987600,1717074000,1717160400,1717419600,1717506000,1717592400,1717678800,1717765200,1718024400,1718110800,1718197200,1718283600,1718370000,1718629200,1718715600,1718888400,1718974800,1719234000,1719320400,1719406800,1719493200,1719579600,1719838800,1719925200,1720011600,1720184400,1720443600,1720530000,1720616400,1720702800,1720789200,1721048400,1721134800,1721221200,1721307600,1721394000,1721653200,1721739600,1721826000,1721912400,1721998800,1722258000,1722344400,1722430800,1722517200,1722603600,1722862800,1722949200,1723035600,1723122000,1723208400,1723467600,1723554000,1723640400,1723726800,1723813200,1724072400,1724158800,1724245200,1724331600,1724418000,1724677200,1724763600,1724850000,1724936400,1725022800,1725368400,1725454800,1725541200,1725627600,1725886800,1725973200,1726059600,1726146000,1726232400,1726491600,1726578000,1726664400,1726750800,1726837200,1727096400,1727182800,1727269200,1727355600,1727442000,1727701200,1727787600,1727874000,1727960400,1728046800,1728306000,1728392400,1728478800,1728565200,1728651600,1728910800,1728997200,1729083600,1729170000,1729256400,1729515600,1729602000,1729688400,1729774800,1729861200,1730120400,1730206800,1730293200,1730379600,1730466000,1730728800,1730815200,1730901600,1730988000,1731074400,1731333600,1731420000,1731506400,1731592800,1731679200,1731938400,1732024800,1732111200,1732197600,1732284000,1732543200,1732629600,1732716000,1732888800,1733148000,1733234400,1733320800,1733407200,1733493600,1733752800,1733839200,1733925600,1734012000,1734098400,1734357600,1734444000,1734530400,1734616800,1734703200,1734962400,1735048800,1735221600,1735308000,1735567200,1735653600,1735826400,1735912800,1736172000,1736258400,1736344800,1736517600,1736776800,1736863200,1736949600,1737036000,1737122400,1737468000,1737554400,1737640800,1737727200,1737986400,1738072800,1738159200,1738245600,1738332000,1738591200,1738677600,1738764000,1738850400,1738936800,1739196000,1739282400,1739368800,1739455200,1739541600,1739887200,1739973600,1740060000,1740146400,1740405600,1740492000,1740578400,1740664800,1740751200,1741010400,1741096800,1741183200,1741269600,1741356000,1741611600,1741698000,1741784400,1741870800,1741957200,1742216400,1742302800,1742389200,1742475600,1742562000,1742821200,1742907600,1742994000,1743080400,1743166800,1743426000,1743512400,1743598800,1743685200,1743771600,1744030800,1744117200,1744203600,1744290000,1744376400,1744635600,1744722000,1744808400,1744894800,1745240400,1745326800,1745413200,1745499600,1745586000,1745845200,1745931600,1746018000,1746104400,1746190800,1746450000,1746536400,1746622800,1746709200,1746795600,1747054800,1747141200,1747227600,1747314000,1747400400,1747659600,1747746000,1747832400,1747918800,1748005200,1748350800,1748437200,1748523600,1748610000,1748869200,1748955600,1749042000,1749128400,1749214800,1749474000,1749560400,1749646800,1749733200,1749819600,1750078800,1750165200,1750251600,1750424400,1750683600,1750770000,1750856400,1750942800,1751029200,1751288400,1751374800,1751461200,1751547600,1751893200,1751979600,1752066000,1752152400,1752238800,1752498000,1752584400,1752670800,1752757200,1752843600,1753102800,1753189200,1753275600,1753362000,1753448400,1753707600],"open":[3.89,3.85,3.71,3.8,3.83,3.88,3.96,4.44,4.48,4.49,4.26,3.89,4.15,4.73,4.15,4.27,4.21,4.15,4.22,4.2,4.1,4.6,4.93,5.05,4.97,4.85,4.65,4.66,4.52,4.54,4.75,4.76,4.64,4.74,4.8,4.75,4.86,4.79,4.75,4.75,4.8,5,5.16,5.08,5.19,4.95,5.4,5.83,5.7,5.61,5.81,5.59,5.42,5.29,5.21,5.17,5.15,4.94,5.1,5.1,4.89,4.76,4.75,4.65,4.85,4.45,4.35,4.24,4.42,4.25,4.53,5.01,5.28,6.21,6.3,6.44,6.1,6.49,7.1,6.69,6.79,6.7,7,7.54,7.3,6.96,7,7.95,7.74,8.57,8.7,8.39,7.88,7.72,8.2,8.18,8.11,7.9,7,7.52,7.57,7.48,7.53,7.22,7.47,7.27,7.22,7.6,7.52,8.05,7.64,7.39,7.53,7.23,7.35,7.69,7.56,7.6,7.76,7.95,7.5,7.63,3.81,3.45,3.17,3.27,3.49,3.46,4.13,3.95,4.35,4.75,4.8,4.6,4.47,4.45,4.24,4.37,4.24,4.83,4.53,4.67,4.51,4.35,4.29,4.17,4.13,4.05,4.28,4.22,4.43,4.44,4.33,4.52,4.23,4.26,4.45,4.51,4.53,4.64,4.55,4.49,4.56,4.51,4.59,4.3,4.2,4.06,4.17,4.22,4.15,4.25,4.4,4.54,4.79,5.01,5.13,5.2,5.58,5.47,5.28,5.41,5.06,5.11,4.96,5.09,5.05,5.17,5.08,4.98,4.7,4.94,4.7,4.4,4.51,4.76,4.41,4.49,4.5,4.99,5.05,4.95,5,5,5.2,5.17,5.26,5.13,5.6,5.73,5.57,5.6,5.57,5.69,5.36,5.6,5.64,5.57,5.64,5.55,5.6,5.63,5.59,5.33,5.49,5.59,5.81,6.03,5.94,5.76,5.97,5.94,5.89,6.39,6.45,6.17,6.42,6.51,6.56,6.52,6.62,6.52,6.35,6.28,6.54,6.54,6.7,6.67,6.52,6.56,6.22,6.36,6.52,6.78,6.49,6.32,6.47,6.29,6.04,6.25,6.3,6.43,6.49,6.78,6.05,6.3,5.95,5.82,5.83,5.9,5.79,5.8,6.06,5.97,6.09,6.46,6.39,6.33,6.08,6,6.05,6.05,5.93,5.98,6,5.9,5.86,5.86,5.9,5.67,5.64,5.68,5.7,5.63,5.68,5.56,5.64,5.61,5.91,6.02,6,6.02,5.88,5.48,5.66,5.27,5.3,5.27,5.22,5.18,5.1,5.24,5.24,5.31,5.41,5.5,5.47,5.41,5.5,5.89,5.95,5.85,5.7,5.82,5.58,6.02,5.92,6,5.83,5.86,5.86,5.78,5.5,5.32,5.25,5.11,5.26,5.07,5.33,5.19,5.32,5.11,5.04,5.52,5.56,5.3,5.29,5.23,5.23,5.36,5.1,5.19,5.17,5,5,5.03,4.91,4.74,4.44,4.54,4.94,4.33,4.76,4.26,4.32,4.18,4.65,4.96,4.86,4.87,4.81,4.94,5.65,5.21,5.4,5.47,5.32,5.39,6.56,6.96,6.52,6.25,5.85,5.25,5.49,5.8,5.58,5.76,5.36,5.755,6.09,6.18,6.38,6.36,6.5,6.47,6.1,6.01,6.1,6.31,6.25,6.28,6.44,6.55,6.78,6.56,6.47,6.2,6.17,6.21,5.93,6.02,6.03,5.87,5.84,5.86,6,5.83,5.79,5.66,5.56,5.85,5.91,5.75,5.85,5.77,5.74,5.71,5.95,6.01,6.26,6.71,6.63,6.75,6.55,6.68,6.63,6.56],"high":[3.95,3.91,3.89,3.99,3.88,3.97,4.49,4.71,4.66,4.5,4.36,4.13,4.5,4.75,4.39,4.33,4.28,4.249,4.247,4.208,4.395,5.38,5.01,5.141,5.098,4.85,4.7,4.66,4.61,4.79,4.88,4.835,4.76,4.78,4.85,4.88,4.9,4.79,4.75,4.78,4.99,5.3,5.185,5.175,5.19,5.56,5.84,5.94,5.897,5.855,5.9,5.62,5.42,5.379,5.24,5.17,5.15,5.03,5.24,5.1,4.95,4.82,4.77,4.95,4.943,4.57,4.45,4.47,4.49,4.41,5.035,5.45,6.33,6.52,7.03,6.44,6.53,7.03,7.5,6.95,6.985,6.98,7.7,7.868,7.32,7.11,7.87,8.24,8.7,9.01,8.805,8.4,8.11,8.48,8.4,8.38,8.87,7.939,7.67,7.74,7.74,7.83,7.68,7.52,7.61,7.46,7.77,7.675,8.12,8.275,7.815,7.57,7.68,7.37,7.84,7.84,7.69,7.89,8.45,8.17,7.69,7.73,4.25,3.52,3.28,3.38,3.78,4.21,4.4,4.28,5.11,4.96,5.065,4.62,4.7,4.5,4.43,4.56,4.94,4.83,4.62,4.67,4.6,4.39,4.3,4.32,4.21,4.19,4.43,4.465,4.7,4.53,4.63,4.56,4.35,4.55,4.66,4.75,4.82,4.65,4.7,4.65,4.71,4.63,4.63,4.31,4.2,4.255,4.24,4.325,4.22,4.39,4.55,4.88,5.194,5.18,5.305,5.6,5.7,5.56,5.52,5.54,5.26,5.33,5.15,5.17,5.26,5.25,5.21,5.005,5,4.94,4.77,4.7,4.78,4.82,4.58,4.57,5.21,5.08,5.299,5.31,5.06,5.25,5.34,5.27,5.26,5.548,5.76,5.73,5.66,5.84,5.75,5.84,5.61,5.68,5.75,5.77,5.64,5.615,5.68,5.75,5.69,5.67,5.61,5.97,6.02,6.18,5.94,6.05,6.04,6.22,6.467,6.48,6.45,6.423,6.6,6.73,6.74,6.67,6.66,6.587,6.48,6.55,6.677,6.78,6.73,6.74,6.62,6.575,6.47,6.64,6.68,6.78,6.64,6.425,6.47,6.29,6.255,6.38,6.48,6.45,6.52,6.78,6.345,6.3,5.98,5.91,5.93,6.01,5.987,6.17,6.19,6.07,6.545,6.46,6.44,6.398,6.11,6.061,6.05,6.055,6.035,6.03,6.04,5.99,6,6,5.905,5.725,5.79,5.72,5.71,5.73,5.725,5.67,5.665,6,6.07,6.057,6.11,6.02,5.96,5.64,5.66,5.425,5.32,5.32,5.269,5.18,5.28,5.35,5.7,5.506,5.483,5.64,5.68,5.57,5.87,6.06,6.06,5.93,5.84,5.82,6.04,6.05,6.16,6.1,5.94,5.915,5.91,5.82,5.68,5.38,5.43,5.26,5.35,5.195,5.58,5.4,5.45,5.165,5.49,5.6,5.6,5.445,5.4,5.345,5.24,5.41,5.35,5.235,5.18,5.17,5.11,5.14,4.96,4.743,4.915,4.985,4.99,4.69,4.84,4.45,4.337,4.67,4.986,5.02,4.93,4.955,4.99,5.315,5.68,5.545,5.48,5.505,5.55,7.324,7.045,7.08,6.689,6.25,5.857,5.515,5.57,6.16,5.745,5.799,5.909,6.12,6.34,6.435,7.17,6.84,6.67,6.595,6.107,6.21,6.28,6.54,6.465,6.525,6.58,6.83,6.84,6.64,6.48,6.31,6.34,6.21,6.24,6.14,6.13,5.92,6.03,6.03,6.03,5.99,5.8,5.715,6.11,5.915,5.91,5.925,5.92,5.875,5.82,5.99,5.98,6.295,6.715,6.92,7.12,6.814,6.78,6.84,6.69,6.68],"low":[3.7,3.71,3.7,3.73,3.72,3.77,3.943,4.32,4.36,4.175,3.93,3.775,3.87,4.14,4.14,4.09,4.13,4.06,4.15,4.09,4.07,4.51,4.66,4.81,4.78,4.57,4.32,4.36,4.46,4.5,4.7,4.58,4.58,4.59,4.63,4.66,4.7,4.62,4.68,4.7,4.72,4.91,5,5.06,4.97,4.95,5.39,5.695,5.532,5.5,5.575,5.33,5.1,5.2,5.1,5.1,4.9,4.88,4.99,4.78,4.729,4.73,4.56,4.65,4.45,4.024,4.03,4.13,4.25,4.25,4.4,4.969,5.28,6.03,6.12,5.84,5.99,6.49,6.16,6.48,6.61,6.6,6.935,7.08,6.87,6.67,6.92,7.45,7.6,8.12,8.19,7.84,7.72,7.4,7.8,7.96,8.03,6.65,6.77,7.41,7.27,7.45,7.34,7.16,7.275,7.1,7.1,7.3,7.461,7.62,7.32,7.12,7.18,7.06,7.32,7.43,7.44,7.53,7.73,7.51,7.2,7.26,3.34,3.14,3.05,3.2,3.37,3.44,3.75,3.84,4.34,4.43,4.54,4.325,4.33,4.09,4.18,4.09,4.24,4.53,4.4,4.343,4.3,4.22,4.1,4.03,4.02,4.01,4.11,4.22,4.38,4.28,4.3,4.248,4.23,4.234,4.4,4.36,4.45,4.51,4.43,4.43,4.49,4.46,4.3,4.1,4.06,4.04,4.07,4.18,4.11,4.16,4.29,4.539,4.79,4.9,5.06,5.2,5.3,5.28,5.17,4.81,5.03,4.97,4.91,4.97,4.99,5.03,4.98,4.71,4.56,4.73,4.63,4.3,4.5,4.41,4.41,4.36,4.5,4.81,4.84,4.94,4.88,4.91,5.05,5.07,5.08,5.13,5.49,5.445,5.37,5.54,5.5,5.38,5.33,5.46,5.335,5.57,5.52,5.45,5.535,5.53,5.32,5.33,5.43,5.57,5.72,5.8,5.69,5.76,5.76,5.85,5.89,6.08,6.06,6.17,6.42,6.39,6.5,6.39,6.41,6.4,6.25,6.15,6.29,6.4,6.63,6.54,6.47,6.22,6.12,6.3,6.339,6.35,6.29,6.04,6.22,5.95,5.97,6.13,6.25,6.25,6.31,6.07,6.03,5.92,5.79,5.631,5.77,5.64,5.62,5.76,5.94,5.934,6.01,6.16,6.26,6.07,5.94,5.935,5.97,5.86,5.85,5.87,5.83,5.8,5.84,5.81,5.56,5.451,5.56,5.57,5.62,5.585,5.57,5.49,5.51,5.6,5.86,5.91,5.93,5.79,5.48,5.31,5.05,5.1,5.165,5.21,5.052,5.055,5.1,5.165,5.24,5.22,5.35,5.44,5.47,5.4,5.5,5.85,5.83,5.67,5.653,5.63,5.58,5.86,5.91,5.79,5.81,5.79,5.76,5.49,5.2,5.19,5.13,5.06,5.09,4.91,5.15,5.02,5.08,4.92,5.03,5.395,5.26,5.28,5.19,5.11,5.08,4.95,5.085,5.075,4.95,4.97,4.989,4.85,4.68,4.42,4.44,4.51,4.4,4.26,4.255,3.933,3.97,4.135,4.57,4.67,4.67,4.815,4.66,4.9,5.11,5.2,5.225,5.07,4.87,5.335,6.37,6.55,6.285,5.75,5.26,5.12,5.25,5.465,5.46,5.35,5.31,5.615,6.05,6.15,6.38,6.21,6.36,6.005,5.97,5.93,5.95,6.145,6.15,6.28,6.3,6.52,6.49,6.24,6.22,6.1,6.125,5.92,5.915,5.93,5.774,5.67,5.75,5.66,5.855,5.69,5.635,5.49,5.495,5.78,5.675,5.74,5.775,5.712,5.655,5.69,5.775,5.975,6.22,6.58,6.63,6.5,6.52,6.64,6.36,6.515],"close":[3.84,3.71,3.79,3.82,3.83,3.96,4.49,4.42,4.4,4.26,3.94,4.09,4.5,4.25,4.15,4.22,4.19,4.22,4.17,4.15,4.31,4.81,4.96,4.9,4.8,4.66,4.64,4.56,4.55,4.75,4.78,4.66,4.68,4.72,4.78,4.87,4.7,4.72,4.73,4.78,4.97,5.09,5.12,5.14,5.01,5.53,5.75,5.76,5.66,5.84,5.63,5.39,5.35,5.25,5.2,5.14,4.97,5,5.08,4.87,4.76,4.76,4.69,4.85,4.48,4.07,4.3,4.42,4.29,4.3,4.9,5.28,6.2,6.48,6.31,6.15,6.49,7.01,6.74,6.75,6.7,6.98,7.54,7.35,6.9,6.9,7.81,7.81,8.46,8.68,8.25,7.97,7.81,8.18,8.23,8.14,8.63,6.99,7.57,7.53,7.53,7.61,7.4,7.36,7.34,7.25,7.72,7.48,8.05,7.7,7.44,7.52,7.44,7.36,7.79,7.55,7.64,7.76,7.93,7.53,7.57,7.36,3.41,3.17,3.19,3.26,3.44,4.14,3.91,4.07,4.6,4.78,4.56,4.4,4.45,4.2,4.3,4.2,4.71,4.6,4.4,4.45,4.31,4.29,4.17,4.06,4.1,4.06,4.21,4.38,4.52,4.33,4.52,4.28,4.27,4.46,4.45,4.5,4.59,4.57,4.51,4.54,4.52,4.58,4.35,4.22,4.09,4.19,4.24,4.2,4.12,4.35,4.54,4.8,5,4.99,5.19,5.51,5.39,5.34,5.42,5.04,5.11,5,5.13,5.05,5.03,5.1,4.98,4.72,4.9,4.81,4.7,4.6,4.68,4.42,4.47,4.42,4.95,4.98,4.95,5,5,5.23,5.13,5.24,5.12,5.515,5.74,5.6,5.54,5.56,5.7,5.46,5.57,5.63,5.55,5.62,5.56,5.59,5.58,5.58,5.33,5.46,5.45,5.8,6.02,5.86,5.76,5.93,5.93,5.89,6.32,6.46,6.23,6.38,6.46,6.54,6.53,6.64,6.58,6.41,6.27,6.54,6.52,6.74,6.67,6.55,6.57,6.25,6.34,6.5,6.39,6.57,6.36,6.41,6.25,6.04,6.21,6.28,6.38,6.4,6.43,6.105,6.1,5.95,5.86,5.855,5.89,5.75,5.79,5.98,5.94,6.03,6.41,6.39,6.34,6.11,6.01,6.015,6.03,5.92,5.98,6.01,5.91,5.89,5.89,5.88,5.63,5.63,5.7,5.69,5.68,5.72,5.63,5.61,5.57,5.91,6.02,6,6,5.96,5.55,5.61,5.09,5.3,5.24,5.22,5.19,5.14,5.25,5.26,5.3,5.41,5.45,5.47,5.54,5.5,5.86,5.88,5.88,5.7,5.82,5.65,6,5.93,6.02,5.85,5.86,5.82,5.78,5.5,5.33,5.26,5.14,5.24,5.09,5.07,5.26,5.3,5.16,5.04,5.46,5.59,5.28,5.29,5.3,5.16,5.2,5.14,5.15,5.12,5,4.99,5.04,4.97,4.76,4.45,4.68,4.95,4.52,4.505,4.32,4.37,4.18,4.6,4.95,4.92,4.85,4.84,4.92,5.28,5.22,5.39,5.33,5.35,5.3,6.56,6.87,6.56,6.4,5.755,5.265,5.49,5.27,5.6,5.63,5.39,5.79,6.1,6.23,6.42,6.45,6.58,6.42,6.12,5.99,6.16,6.24,6.28,6.27,6.44,6.48,6.74,6.54,6.46,6.22,6.245,6.16,5.965,6,6,5.89,5.81,5.86,5.98,5.9,5.75,5.68,5.57,5.87,5.89,5.75,5.84,5.83,5.85,5.74,5.92,5.95,6.26,6.63,6.59,6.75,6.52,6.71,6.65,6.53,6.645],"lastOpen":6.559999942779541,"lastHigh":6.679999828338623,"lastLow":6.514999866485596,"lastClose":6.644999980926514,"lastVolume":202459,"dataId":"202459|6.645","lastDate":20250728,"lastTime":1753719594,"prevClose":6.53000020980835,"afterClose":null,"afterChange":null,"afterTime":null,"updateOhlcVersion":147,"chartEvents":[{"dateTimestamp":1699882200,"eventType":"chartEvent/earnings","fiscalPeriod":"2023Q3","fiscalEndDate":1696046400,"epsActual":-0.48,"epsEstimate":-0.5333,"epsReportedActual":-0.48,"epsReportedEstimate":-0.5333,"salesActual":0,"salesEstimate":0},{"dateTimestamp":1710765000,"eventType":"chartEvent/earnings","fiscalPeriod":"2023Q4","fiscalEndDate":1703998800,"epsActual":-0.59,"epsEstimate":-0.47,"epsReportedActual":-0.59,"epsReportedEstimate":-0.47,"salesActual":0,"salesEstimate":0},{"dateTimestamp":1715776200,"eventType":"chartEvent/earnings","fiscalPeriod":"2024Q1","fiscalEndDate":1711857600,"epsActual":-1.16,"epsEstimate":-0.5133,"epsReportedActual":-1.16,"epsReportedEstimate":-0.5133,"salesActual":0,"salesEstimate":0.1667},{"dateTimestamp":1723465800,"eventType":"chartEvent/earnings","fiscalPeriod":"2024Q2","fiscalEndDate":1719720000,"epsActual":-0.26,"epsEstimate":-0.342,"epsReportedActual":-0.26,"epsReportedEstimate":-0.342,"salesActual":0,"salesEstimate":0.1},{"dateTimestamp":1731591000,"eventType":"chartEvent/earnings","fiscalPeriod":"2024Q3","fiscalEndDate":1727668800,"epsActual":-0.63,"epsEstimate":-0.3925,"epsReportedActual":-0.63,"epsReportedEstimate":-0.3925,"salesActual":0,"salesEstimate":0.1},{"dateTimestamp":1742473800,"eventType":"chartEvent/earnings","fiscalPeriod":"2024Q4","fiscalEndDate":1735621200,"epsActual":0.5,"epsEstimate":-0.348,"epsReportedActual":0.5,"epsReportedEstimate":-0.348,"salesActual":0,"salesEstimate":0.1},{"dateTimestamp":1747312200,"eventType":"chartEvent/earnings","fiscalPeriod":"2025Q1","fiscalEndDate":1743393600,"epsActual":-0.24,"epsEstimate":-0.358,"epsReportedActual":-0.24,"epsReportedEstimate":-0.358,"salesActual":0,"salesEstimate":0}],"patterns":[{"kind":1,"strength":31404.582,"status":0,"bounces":0,"x1":0,"y1":56,"x2":600,"y2":56,"x3":0,"y3":0,"x4":0,"y4":0,"ticker":""},{"kind":2,"strength":1671.3684,"status":0,"bounces":2,"x1":425,"y1":40,"x2":600,"y2":70,"x3":0,"y3":0,"x4":0,"y4":0,"ticker":""},{"kind":2,"strength":151.81877,"status":2,"bounces":2,"x1":265,"y1":111,"x2":600,"y2":-36,"x3":0,"y3":0,"x4":0,"y4":0,"ticker":""},{"kind":3,"strength":418.44687,"status":1,"bounces":2,"x1":382,"y1":249,"x2":600,"y2":112,"x3":0,"y3":0,"x4":0,"y4":0,"ticker":""},{"kind":3,"strength":158.52475,"status":2,"bounces":2,"x1":437,"y1":168,"x2":600,"y2":134,"x3":0,"y3":0,"x4":0,"y4":0,"ticker":""},{"kind":8,"strength":514.7361,"status":0,"bounces":3,"x1":425,"y1":40,"x2":600,"y2":70,"x3":437,"y3":168,"x4":600,"y4":134,"ticker":""},{"kind":4,"strength":252.04779,"status":1,"bounces":3,"x1":265,"y1":111,"x2":600,"y2":-36,"x3":382,"y3":249,"x4":600,"y4":112,"ticker":""}],"patternsMinRange":3.5,"patternsMaxRange":7.5};
                        data.instrument = 'stock';
                        data.premarket = 0;
                        data.aftermarket = 0;
                        data.hasPatterns = true;
                        data.events = true;
                        data.financialAttachments = [];
                        window.globalChartConfig.quoteData = data;
                    </script></div><div class="fv-container">
<table width="100%" cellpadding="0" cellspacing="0" border="0">
<tbody><tr>
<td align="center" valign="top">
<div class="content" data-testid="quote-data-content"><table style="table-layout:fixed" width="100%"><tbody><tr>
<td align="center" valign="top">
<div class="mt-1"><div id="IC_D_970x91_1" class="relative overflow-hidden flex items-center justify-center w-full mx-auto" style="width:970px;height:100px;max-height:100px"></div></div><table width="100%" cellpding="0" cellspacing="0" class="fullview-links table-fixed">
<tbody>
<tr>
<td class="js-quote-correlation-links-container" align="left" height="20">
<div class="flex">
<div class="flex-1 max-w-max truncate">
<a class="tab-link" href="screener.ashx?t=BMRN,QURE,SRPT,SGMO,BLUE,CLGN,ADVM,FATE,VYGR,NTLA">Peers</a>:<span style="font-size:11px"> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=BMRN&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=BMRN&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Biomarin Pharmaceutical Inc</b>Biotechnology <span>•</span> USA <span>•</span> 11.34B </div>] offsetx=[0] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=BMRN&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">BMRN</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=QURE&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=QURE&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>uniQure N.V</b>Biotechnology <span>•</span> Netherlands <span>•</span> 820.94M </div>] offsetx=[0] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=QURE&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">QURE</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=SRPT&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=SRPT&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Sarepta Therapeutics Inc</b>Biotechnology <span>•</span> USA <span>•</span> 1.30B </div>] offsetx=[0] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=SRPT&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">SRPT</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=SGMO&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=SGMO&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Sangamo Therapeutics Inc</b>Biotechnology <span>•</span> USA <span>•</span> 158.29M </div>] offsetx=[0] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=SGMO&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">SGMO</a></span> <span class="inline-flex" "=""><a href="quote.ashx?t=BLUE&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">BLUE</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=CLGN&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=CLGN&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>CollPlant Biotechnologies Ltd</b>Biotechnology <span>•</span> Israel <span>•</span> 28.62M </div>] offsetx=[0] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=CLGN&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">CLGN</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=ADVM&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=ADVM&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Adverum Biotechnologies Inc</b>Biotechnology <span>•</span> USA <span>•</span> 56.19M </div>] offsetx=[0] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=ADVM&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">ADVM</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=FATE&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=FATE&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Fate Therapeutics Inc</b>Biotechnology <span>•</span> USA <span>•</span> 152.92M </div>] offsetx=[0] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=FATE&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">FATE</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VYGR&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VYGR&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Voyager Therapeutics Inc</b>Biotechnology <span>•</span> USA <span>•</span> 184.05M </div>] offsetx=[0] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=VYGR&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">VYGR</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=NTLA&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=NTLA&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Intellia Therapeutics Inc</b>Biotechnology <span>•</span> USA <span>•</span> 1.37B </div>] offsetx=[0] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=NTLA&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">NTLA</a></span></span></div><div class="flex-1 max-w-max truncate">
&nbsp;|&nbsp;<a class="tab-link" href="screener.ashx?t=VTI,IWM,VXF,SURI,IWO,VTWO,ITOT,IWC,VFMO,VTWG">Held by</a>:<span style="font-size:11px"> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VTI&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VTI&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Vanguard Total Stock Market ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 517.28B </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=VTI&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">VTI</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=IWM&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=IWM&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>iShares Russell 2000 ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 65.22B </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=IWM&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">IWM</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VXF&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VXF&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Vanguard Extended Market Index ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 23.16B </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=VXF&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">VXF</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=SURI&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=SURI&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Simplify Propel Opportunities ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 68.26M </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=SURI&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">SURI</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=IWO&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=IWO&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>iShares Russell 2000 Growth ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 11.94B </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=IWO&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">IWO</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VTWO&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VTWO&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Vanguard Russell 2000 Index ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 12.06B </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=VTWO&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">VTWO</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=ITOT&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=ITOT&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>iShares Core S&amp;P Total U.S. Stock Market ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 73.57B </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=ITOT&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">ITOT</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=IWC&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=IWC&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>iShares Micro-Cap ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 866.89M </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=IWC&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">IWC</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VFMO&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VFMO&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Vanguard U.S. Momentum Factor ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 1.12B </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=VFMO&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">VFMO</a></span> <span class="inline-flex" data-boxover="cssbody=[hoverchart] cssheader=[tabchrthdr] body=[<img  srcset='https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VTWG&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d 1x, https://charts2-node.finviz.com/chart.ashx?cs=m&amp;t=VTWG&amp;tf=d&amp;s=linear&amp;pm=0&amp;am=0&amp;ct=candle_stick&amp;tm=d&amp;sf=2 2x' width='324' height='180' alt='' loading='lazy'><div><b>Vanguard Russell 2000 Growth Index ETF</b>Exchange Traded Fund <span>•</span> USA <span>•</span> AUM: 1.02B </div>] offsetx=[-470] offsety=[0] delay=[250]" "=""><a href="quote.ashx?t=VTWG&amp;ty=c&amp;ta=1&amp;p=d" class="tab-link">VTWG</a></span></span></div><div class="ml-auto flex-none pl-2">
    <a class="tab-link whitespace-nowrap" href="#statements">Scroll to Statements<svg width="12" height="12" class="fill-current inline-block ml-0.5">
    <use href="/assets/dist-icons/icons.svg?rev=26#arrowDown"></use>
</svg></a></div>
</div>
</td>
</tr>
</tbody>
</table>
<div style="overflow:hidden;" class="screener_snapshot-table-wrapper js-snapshot-table-wrapper"><table width="100%" cellpadding="3" cellspacing="0" border="0" class="js-snapshot-table snapshot-table2 screener_snapshot-table-body">
<tbody><tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Major index membership] offsetx=[10] offsety=[20] delay=[300]">Index</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>RUT</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Earnings (ttm)] offsetx=[10] offsety=[20] delay=[300]">P/E</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Diluted EPS (ttm)] offsetx=[10] offsety=[20] delay=[300]">EPS (ttm)</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-1.34</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Insider ownership] offsetx=[10] offsety=[20] delay=[300]">Insider Own</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>11.11%</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Shares outstanding] offsetx=[10] offsety=[20] delay=[300]">Shs Outstand</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>48.95M</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Week, Excl. Dividends)] offsetx=[10] offsety=[20] delay=[300]">Perf Week</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-negative">-1.56%</span></b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Market capitalization] offsetx=[10] offsety=[20] delay=[300]">Market Cap</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>339.93M</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Forward Price-to-Earnings (next fiscal year)] offsetx=[10] offsety=[20] delay=[300]">Forward P/E</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>48.62</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS estimate for next year] offsetx=[10] offsety=[20] delay=[300]">EPS next Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>0.14</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Insider transactions (6-Month change in Insider Ownership)] offsetx=[10] offsety=[20] delay=[300]">Insider Trans</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-4.60%</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Shares float] offsetx=[10] offsety=[20] delay=[300]">Shs Float</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>45.48M</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Month, Excl. Dividends)] offsetx=[10] offsety=[20] delay=[300]">Perf Month</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">12.63%</span></b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Enterprise Value] offsetx=[10] offsety=[20] delay=[300]">Enterprise Value</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>279.42M</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Earnings-to-Growth] offsetx=[10] offsety=[20] delay=[300]">PEG</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS estimate for next quarter] offsetx=[10] offsety=[20] delay=[300]">EPS next Q</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-0.39</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Institutional ownership] offsetx=[10] offsety=[20] delay=[300]">Inst Own</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>58.63%</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Short interest share] offsetx=[10] offsety=[20] delay=[300]"><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=si" class="hover:underline">Short Float</a></td><td class="snapshot-td2 w-[8%] " align="left" style=""><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=si" class="hover:underline"><b>18.65%</b></a></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Quarter, Excl. Dividends)] offsetx=[10] offsety=[20] delay=[300]">Perf Quarter</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">24.67%</span></b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Income (ttm)] offsetx=[10] offsety=[20] delay=[300]">Income</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-44.19M</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Sales (ttm)] offsetx=[10] offsety=[20] delay=[300]">P/S</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS growth this year] offsetx=[10] offsety=[20] delay=[300]">EPS this Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">66.02%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Institutional transactions (3-Month change in Institutional Ownership)] offsetx=[10] offsety=[20] delay=[300]">Inst Trans</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>9.27%</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Short interest ratio] offsetx=[10] offsety=[20] delay=[300]"><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=si" class="hover:underline">Short Ratio</a></td><td class="snapshot-td2 w-[8%] " align="left" style=""><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=si" class="hover:underline"><b>4.82</b></a></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Half Year, Excl. Dividends)] offsetx=[10] offsety=[20] delay=[300]">Perf Half Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">26.33%</span></b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Revenue (ttm)] offsetx=[10] offsety=[20] delay=[300]">Sales</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>0.00M</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Book (mrq)] offsetx=[10] offsety=[20] delay=[300]">P/B</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-negative">7.86</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS growth next year] offsetx=[10] offsety=[20] delay=[300]">EPS next Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">125.95%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Return on Assets (ttm)] offsetx=[10] offsety=[20] delay=[300]">ROA</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-negative">-50.73%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Short interest] offsetx=[10] offsety=[20] delay=[300]"><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=si" class="hover:underline">Short Interest</a></td><td class="snapshot-td2 w-[8%] " align="left" style=""><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=si" class="hover:underline"><b data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Settlement Date: 7/24/2025] offsetx=[10] offsety=[20] delay=[500]">8.48M</b></a></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Year To Date, Excl. Dividends)] offsetx=[10] offsety=[20] delay=[300]">Perf YTD</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">19.30%</span></b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Book value per share (mrq)] offsetx=[10] offsety=[20] delay=[300]">Book/sh</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>0.85</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price to cash per share (mrq)] offsetx=[10] offsety=[20] delay=[300]">P/C</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>4.02</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Long term annual growth estimate (5 years)] offsetx=[10] offsety=[20] delay=[300]">EPS next 5Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Return on Equity (ttm)] offsetx=[10] offsety=[20] delay=[300]">ROE</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-negative">-271.78%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 52-Week High] offsetx=[10] offsety=[20] delay=[300]">52W High</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>7.32 <span class="color-text is-negative">-9.27%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Year, Excl. Dividends)] offsetx=[10] offsety=[20] delay=[300]">Perf Year</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">31.58%</span></b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Cash per share (mrq)] offsetx=[10] offsety=[20] delay=[300]">Cash/sh</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>1.65</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price to Free Cash Flow (ttm)] offsetx=[10] offsety=[20] delay=[300]">P/FCF</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Annual EPS growth past 3 and 5 years] offsetx=[10] offsety=[20] delay=[300]">EPS past 3/5Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><small><span class="color-text is-positive">58.40%</span> <span class="color-text is-positive">47.21%</span></small></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Return on Invested Capital (ttm)] offsetx=[10] offsety=[20] delay=[300]">ROIC</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-negative">-78.05%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 52-Week Low] offsetx=[10] offsety=[20] delay=[300]">52W Low</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>3.93 <span class="color-text is-positive">68.96%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (3 Years, Excl. Dividends)] offsetx=[10] offsety=[20] delay=[300]">Perf 3Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">30.29%</span></b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Analysts' Dividend Estimate (Fiscal Year)] offsetx=[10] offsety=[20] delay=[300]">Dividend Est.</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Enterprise Value to EBITDA] offsetx=[10] offsety=[20] delay=[300]">EV/EBITDA</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Annual sales growth past 3 and 5 years] offsetx=[10] offsety=[20] delay=[300]">Sales past 3/5Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><small>- -</small></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Gross Margin (ttm)] offsetx=[10] offsety=[20] delay=[300]">Gross Margin</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Volatility (Week, Month)] offsetx=[10] offsety=[20] delay=[300]">Volatility</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><small>4.88% 4.58%</small></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (5 Years, Excl. Dividends)] offsetx=[10] offsety=[20] delay=[300]">Perf 5Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-negative">-91.17%</span></b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Trailing 12 Months Dividend] offsetx=[10] offsety=[20] delay=[300]">Dividend TTM</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Enterprise Value to Revenues] offsetx=[10] offsety=[20] delay=[300]">EV/Sales</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS growth TTM] offsetx=[10] offsety=[20] delay=[300]">EPS Y/Y TTM</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">72.26%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Operating Margin (ttm)] offsetx=[10] offsety=[20] delay=[300]">Oper. Margin</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Average True Range (14)] offsetx=[10] offsety=[20] delay=[300]">ATR (14)</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>0.29</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (10 Years, Excl. Dividends)] offsetx=[10] offsety=[20] delay=[300]">Perf 10Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-negative">-95.41%</span></b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Ex-Dividend Date] offsetx=[10] offsety=[20] delay=[300]">Dividend Ex-Date</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Quick Ratio (mrq)] offsetx=[10] offsety=[20] delay=[300]">Quick Ratio</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">4.90</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Sales growth TTM] offsetx=[10] offsety=[20] delay=[300]">Sales Y/Y TTM</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-negative">-100.00%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Net Profit Margin (ttm)] offsetx=[10] offsety=[20] delay=[300]">Profit Margin</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Relative Strength Index] offsetx=[10] offsety=[20] delay=[300]">RSI (14)</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>61.27</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Analysts' mean recommendation (1=Buy 5=Sell)] offsetx=[10] offsety=[20] delay=[300]"><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=fc" class="hover:underline">Recom</a></td><td class="snapshot-td2 w-[8%] " align="left" style=""><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=fc" class="hover:underline"><b><span class="color-text is-positive">1.00</span></b></a></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Dividend growth over 3 and 5 years] offsetx=[10] offsety=[20] delay=[300]">Dividend Gr. 3/5Y</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><small>- -</small></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Current Ratio (mrq)] offsetx=[10] offsety=[20] delay=[300]">Current Ratio</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">4.90</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Quarterly earnings growth (YoY)] offsetx=[10] offsety=[20] delay=[300]">EPS Q/Q</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">79.10%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 20-Day Simple Moving Average] offsetx=[10] offsety=[20] delay=[300]">SMA20</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">7.90%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Beta] offsetx=[10] offsety=[20] delay=[300]">Beta</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>1.55</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Analysts' mean target price] offsetx=[10] offsety=[20] delay=[300]"><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=fc" class="hover:underline">Target Price</a></td><td class="snapshot-td2 w-[8%] " align="left" style=""><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=fc" class="hover:underline"><b><span class="color-text is-positive">19.93</span></b></a></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Dividend Payout Ratio (ttm)] offsetx=[10] offsety=[20] delay=[300]">Payout</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Total Debt to Equity (mrq)] offsetx=[10] offsety=[20] delay=[300]">Debt/Eq</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-negative">0.58</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Quarterly revenue growth (YoY)] offsetx=[10] offsety=[20] delay=[300]">Sales Q/Q</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>-</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 50-Day Simple Moving Average] offsetx=[10] offsety=[20] delay=[300]">SMA50</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">7.64%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Relative volume] offsetx=[10] offsety=[20] delay=[300]">Rel Volume</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>0.25</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Previous close] offsetx=[10] offsety=[20] delay=[300]">Prev Close</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>6.53</b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Full time employees] offsetx=[10] offsety=[20] delay=[300]">Employees</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>136</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Long Term Debt to Equity (mrq)] offsetx=[10] offsety=[20] delay=[300]">LT Debt/Eq</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>0.37</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Earnings date<br><br>BMO = Before Market Open<br>AMC = After Market Close] offsetx=[10] offsety=[20] delay=[300]"><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=ea" class="hover:underline">Earnings</a></td><td class="snapshot-td2 w-[8%] " align="left" style=""><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=ea" class="hover:underline"><b>May 15 BMO</b></a></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 200-Day Simple Moving Average] offsetx=[10] offsety=[20] delay=[300]">SMA200</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">14.73%</span></b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Average volume (3 month)] offsetx=[10] offsety=[20] delay=[300]">Avg Volume</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>1.76M</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Current stock price] offsetx=[10] offsety=[20] delay=[300]">Price</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>6.64</b></td>
</tr>
<tr class="table-dark-row">
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[IPO Date] offsetx=[10] offsety=[20] delay=[300]">IPO</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>Sep 19, 1980</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Stock has options trading on a market exchange / Stock is avaiable to sell short] offsetx=[10] offsety=[20] delay=[300]">Option/Short</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>Yes / Yes</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Last quarter EPS and Revenue surprise] offsetx=[10] offsety=[20] delay=[300]"><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=ea" class="hover:underline">EPS/Sales Surpr.</a></td><td class="snapshot-td2 w-[8%] " align="left" style=""><a href="quote.ashx?t=ABEO&amp;ta=1&amp;p=d&amp;ty=ea" class="hover:underline"><b><small><span class="color-text is-positive">32.96%</span> -</small></b></a></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Trades] offsetx=[10] offsety=[20] delay=[300]">Trades</td><td class="snapshot-td2 w-[8%] " align="left" style=""><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=etf-fundamentals"><svg width="16" height="16" class="text-muted -ml-0.5">
    <use href="/assets/dist-icons/icons.svg?rev=26#lockOutline"></use>
</svg></a></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Volume] offsetx=[10] offsety=[20] delay=[300]">Volume</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b>202,459</b></td>
<td class="snapshot-td2 cursor-pointer w-[7%]" align="left" data-boxover="cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (today)] offsetx=[10] offsety=[20] delay=[300]">Change</td><td class="snapshot-td2 w-[8%] " align="left" style=""><b><span class="color-text is-positive">1.76%</span></b></td>
</tr>
</tbody></table>
</div>
</td>
</tr>
</tbody></table>
<table width="100%" cellpadding="0" cellspacing="0" border="0">
<tbody><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px" width="2" height="2"></td></tr>
<tr><td align="center"><div id="IC_D_3x6_1" class="relative overflow-hidden flex items-center justify-center w-full mx-auto" style="width:970px;height:315px;max-height:315px"></div></td></tr><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px" width="2" height="2"></td></tr>
<tr class="js-ratings-row">
<td>
<table width="100%" class="js-table-ratings styled-table-new is-rounded is-small" cellpadding="0" cellspacing="0" border="0">
<thead>
                <tr>
                    <th width="140" align="left">Date</th>
                    <th width="320" align="left">Action</th>
                    <th width="320" align="left">Analyst</th>
                    <th width="320" align="left">Rating Change</th>
                    <th width="320" align="left">Price Target Change</th>
                </tr>
            </thead><tbody><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text"><td width="140" align="left">Jun-02-25</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Resumed</span></td>
<td class="text-left" width="320" align="left">Oppenheimer</td>
<td class="text-left" width="320" align="left">Outperform</td>
<td class="text-left tabular-nums" width="320" align="left">$19</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text"><td width="140" align="left">Mar-05-25</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">Oppenheimer</td>
<td class="text-left" width="320" align="left">Outperform</td>
<td class="text-left tabular-nums" width="320" align="left">$16</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text"><td width="140" align="left">Jul-03-24</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">H.C. Wainwright</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left">$15</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text"><td width="140" align="left">May-30-24</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">Stifel</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left">$21</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text"><td width="140" align="left">Nov-11-20</td><td width="320" align="left"><span class="fv-label is-small is-positive-200">Upgrade</span></td>
<td class="text-left color-text is-positive" width="320" align="left">Cantor Fitzgerald</td>
<td class="text-left color-text is-positive" width="320" align="left">Neutral → Overweight</td>
<td class="text-left tabular-nums color-text is-positive" width="320" align="left">$4</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text"><td width="140" align="left">Sep-18-20</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">B. Riley FBR</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left">$5</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text"><td width="140" align="left">Feb-10-20</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">SVB Leerink</td>
<td class="text-left" width="320" align="left">Outperform</td>
<td class="text-left tabular-nums" width="320" align="left">$6</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text"><td width="140" align="left">Dec-10-19</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Resumed</span></td>
<td class="text-left" width="320" align="left">Cantor Fitzgerald</td>
<td class="text-left" width="320" align="left">Neutral</td>
<td class="text-left tabular-nums" width="320" align="left">$2 → $4</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text"><td width="140" align="left">Aug-15-19</td><td width="320" align="left"><span class="fv-label is-small is-negative-200">Downgrade</span></td>
<td class="text-left color-text is-negative" width="320" align="left">Maxim Group</td>
<td class="text-left color-text is-negative" width="320" align="left">Buy → Hold</td>
<td class="text-left tabular-nums color-text is-negative" width="320" align="left"></td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text is-last"><td width="140" align="left">Aug-12-19</td><td width="320" align="left"><span class="fv-label is-small is-negative-200">Downgrade</span></td>
<td class="text-left color-text is-negative" width="320" align="left">Cantor Fitzgerald</td>
<td class="text-left color-text is-negative" width="320" align="left">Overweight → Neutral</td>
<td class="text-left tabular-nums color-text is-negative" width="320" align="left">$29 → $2</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Jul-26-19</td><td width="320" align="left"><span class="fv-label is-small is-negative-200">Downgrade</span></td>
<td class="text-left color-text is-negative" width="320" align="left">Mizuho</td>
<td class="text-left color-text is-negative" width="320" align="left">Buy → Neutral</td>
<td class="text-left tabular-nums color-text is-negative" width="320" align="left">$17 → $4</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Jun-27-19</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">Mizuho</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left"></td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Oct-12-18</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">Mizuho</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left">$17</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Jun-05-18</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">Seaport Global Securities</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left">$29</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Nov-08-17</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">SunTrust</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left">$26</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Oct-16-17</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Reiterated</span></td>
<td class="text-left" width="320" align="left">H.C. Wainwright</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left">$20 → $30</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Oct-11-17</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Reiterated</span></td>
<td class="text-left" width="320" align="left">Cantor Fitzgerald</td>
<td class="text-left" width="320" align="left">Overweight</td>
<td class="text-left tabular-nums" width="320" align="left">$21 → $34</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Oct-10-17</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">Citigroup</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left">$32</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Oct-05-17</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Reiterated</span></td>
<td class="text-left" width="320" align="left">Maxim Group</td>
<td class="text-left" width="320" align="left">Buy</td>
<td class="text-left tabular-nums" width="320" align="left">$17 → $35</td>
</tr>
<tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders has-label has-color-text hidden"><td width="140" align="left">Sep-15-17</td><td width="320" align="left"><span class="fv-label is-small is-neutral">Initiated</span></td>
<td class="text-left" width="320" align="left">RBC Capital Mkts</td>
<td class="text-left" width="320" align="left">Outperform</td>
<td class="text-left tabular-nums" width="320" align="left">$23</td>
</tr>
</tbody></table>
</td>
</tr>
<tr class="js-reveal-ratings-button">
    <td class="fullview-links">
        <a href="" class="tab-link">
            <svg width="16" height="16" class="fill-current inline-block mb-0.5">
    <use href="/assets/dist-icons/icons.svg?rev=26#chevronDown"></use>
</svg>
            Show Previous Ratings
        </a>
    </td>
</tr><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px" width="2" height="2"></td></tr>
<tr>
<td>
<table width="100%" cellpadding="0" cellspacing="0"><tbody><tr><td><div class="body-table-news-wrapper news-table_wrapper"><table width="100%" cellpadding="1" cellspacing="0" border="0" id="news-table" class="fullview-news-outer news-table">
    <tbody><tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/103659/zevaskyn-gene-therapy-now-available-at-new-qualified-treatment-center-in-san-francisco-bay-area');">
        <td width="130" align="right">
            Jul-15-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/103659/zevaskyn-gene-therapy-now-available-at-new-qualified-treatment-center-in-san-francisco-bay-area" target="_blank">ZEVASKYN Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'PR Newswire', '/news/102463/bio-technes-simple-western-technology-utilized-in-recent-fda-approval-of-zevaskyn-cell-based-gene-therapy');">
        <td width="130" align="right">
            Jul-14-25 07:00AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/102463/bio-technes-simple-western-technology-utilized-in-recent-fda-approval-of-zevaskyn-cell-based-gene-therapy" target="_blank">Bio-Techne's Simple Western Technology Utilized in Recent FDA Approval of ZEVASKYN Cell-Based Gene Therapy</a>
                </div>
                <div class="news-link-right">
                    <span>(PR Newswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/94031/abeona-therapeutics-closes-sale-of-rare-pediatric-disease-priority-review-voucher-for-155-million');">
        <td width="130" align="right">
            Jul-02-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/94031/abeona-therapeutics-closes-sale-of-rare-pediatric-disease-priority-review-voucher-for-155-million" target="_blank">Abeona Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +5.39%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/92956/abeona-therapeutics-announces-option-exercise-by-beacon-therapeutics-for-novel-aav204-capsid-for-ophthalmology-gene-therapy');">
        <td width="130" align="right">
            Jul-01-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/92956/abeona-therapeutics-announces-option-exercise-by-beacon-therapeutics-for-novel-aav204-capsid-for-ophthalmology-gene-therapy" target="_blank">Abeona Therapeutics Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/92920/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4');">
        <td width="130" align="right">
            07:15AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/92920/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4" target="_blank">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>

                        <tr>
                            <td width="130" align="right">07:30AM</td>
                            <td align="left" id="IC_D_3x8_1"><span class="block text-2xs text-gray-500 leading-none">Loading…</span></td>
                        </tr>
                      <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/91848/abeona-therapeutics-added-to-membership-of-us-small-cap-russell-2000-index-and-broad-market-russell-3000-index');">
        <td width="130" align="right">
            Jun-30-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/91848/abeona-therapeutics-added-to-membership-of-us-small-cap-russell-2000-index-and-broad-market-russell-3000-index" target="_blank">Abeona Therapeutics added to Membership of U.S. Small-cap Russell 2000 Index and Broad-market Russell 3000 Index</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/86726/abeona-therapeutics-announces-publication-in-the-lancet-of-phase-3-viital-study-data-in-recessive-dystrophic-epidermolysis-bullosa');">
        <td width="130" align="right">
            Jun-24-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/86726/abeona-therapeutics-announces-publication-in-the-lancet-of-phase-3-viital-study-data-in-recessive-dystrophic-epidermolysis-bullosa" target="_blank">Abeona Therapeutics Announces Publication in The Lancet of Phase 3 VIITAL Study Data in Recessive Dystrophic Epidermolysis Bullosa</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/71185/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4');">
        <td width="130" align="right">
            Jun-02-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/71185/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4" target="_blank">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/70222/abeona-therapeutics-to-present-at-the-jefferies-global-healthcare-conference');">
        <td width="130" align="right">
            May-30-25 08:46AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/70222/abeona-therapeutics-to-present-at-the-jefferies-global-healthcare-conference" target="_blank">Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Associated Press Finance', 'https://finance.yahoo.com/news/abeona-therapeutics-q1-earnings-snapshot-113829928.html');">
        <td width="130" align="right">
            May-15-25 07:38AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-q1-earnings-snapshot-113829928.html" target="_blank" rel="nofollow">Abeona Therapeutics: Q1 Earnings Snapshot</a>
                </div>
                <div class="news-link-right">
                    <span>(Associated Press Finance)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +7.42%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/58276/abeona-therapeutics-reports-first-quarter-2025-financial-results-and-corporate-updates');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/58276/abeona-therapeutics-reports-first-quarter-2025-financial-results-and-corporate-updates" target="_blank">Abeona Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/57113/update-abeona-therapeutics-and-lurie-childrens-open-first-center-for-zevaskyn-gene-therapy-to-treat-wounds-in-painful-skin-disorder');">
        <td width="130" align="right">
            May-14-25 08:07AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/57113/update-abeona-therapeutics-and-lurie-childrens-open-first-center-for-zevaskyn-gene-therapy-to-treat-wounds-in-painful-skin-disorder" target="_blank">UPDATE -- Abeona Therapeutics and Lurie Children's Open First Center for ZEVASKYN Gene Therapy to Treat Wounds in Painful Skin Disorder</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/57009/abeona-therapeutics-and-lurie-childrens-open-first-center-for-zevaskyntm-gene-therapy-to-treat-wounds-in-painful-skin-disorder');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/57009/abeona-therapeutics-and-lurie-childrens-open-first-center-for-zevaskyntm-gene-therapy-to-treat-wounds-in-painful-skin-disorder" target="_blank">Abeona Therapeutics and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/57043/abeona-therapeutics-and-lurie-childrens-open-first-center-for-zevaskyn-gene-therapy-to-treat-wounds-in-painful-skin-disorder');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/57043/abeona-therapeutics-and-lurie-childrens-open-first-center-for-zevaskyn-gene-therapy-to-treat-wounds-in-painful-skin-disorder" target="_blank">Abeona Therapeutics and Lurie Children's Open First Center for ZEVASKYN Gene Therapy to Treat Wounds in Painful Skin Disorder</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Pharmaceutical Technology', 'https://finance.yahoo.com/m/8cd01ba2-4dcb-3f9e-ba2b-86cd500881ac/abeona-secures-cash-runway.html');">
        <td width="130" align="right">
            May-13-25 07:21AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/m/8cd01ba2-4dcb-3f9e-ba2b-86cd500881ac/abeona-secures-cash-runway.html" target="_blank" rel="nofollow">Abeona secures cash runway with $155m priority review voucher sale</a>
                </div>
                <div class="news-link-right">
                    <span>(Pharmaceutical Technology)</span></div></div></td></tr>

                        <tr>
                            <td width="130" align="right">07:30AM</td>
                            <td align="left" id="IC_D_3x8_2"><span class="block text-2xs text-gray-500 leading-none">Loading…</span></td>
                        </tr>
                      <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/54415/abeona-therapeutics-enters-into-agreement-to-sell-priority-review-voucher-for-155-million');">
        <td width="130" align="right">
            May-12-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/54415/abeona-therapeutics-enters-into-agreement-to-sell-priority-review-voucher-for-155-million" target="_blank">Abeona Therapeutics Enters into Agreement to Sell Priority Review Voucher for $155 Million</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +6.26%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'BioPharma Dive', 'https://finance.yahoo.com/m/5114a970-9ef9-349f-9497-f4dee0cb0851/abeona-sells-speedy-drug.html');">
        <td width="130" align="right">
            04:38AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/m/5114a970-9ef9-349f-9497-f4dee0cb0851/abeona-sells-speedy-drug.html" target="_blank" rel="nofollow">Abeona sells speedy drug review voucher for $155M</a>
                </div>
                <div class="news-link-right">
                    <span>(BioPharma Dive)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', '/news/50703/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4');">
        <td width="130" align="right">
            May-07-25 04:59PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="/news/50703/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4" target="_blank">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-loss is-negative-200"> -8.51%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Pharmaceutical Technology', 'https://finance.yahoo.com/m/c8158f80-5671-3287-a085-4bea864638b9/fda-approves-abeona%E2%80%99s-%243.1m.html');">
        <td width="130" align="right">
            Apr-30-25 07:16AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/m/c8158f80-5671-3287-a085-4bea864638b9/fda-approves-abeona%E2%80%99s-%243.1m.html" target="_blank" rel="nofollow">FDA approves Abeonas $3.1m cell therapy for rare skin disease</a>
                </div>
                <div class="news-link-right">
                    <span>(Pharmaceutical Technology)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +23.77%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Benzinga', 'https://finance.yahoo.com/news/abeona-therapeutics-wins-fda-approval-190643632.html');">
        <td width="130" align="right">
            Apr-29-25 03:06PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-wins-fda-approval-190643632.html" target="_blank" rel="nofollow">Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy</a>
                </div>
                <div class="news-link-right">
                    <span>(Benzinga)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2025/04/29/3069976/0/en/U-S-FDA-Approves-ZEVASKYN-prademagene-zamikeracel-the-First-and-Only-Cell-Based-Gene-Therapy-for-Patients-with-Recessive-Dystrophic-Epidermolysis-Bullosa-RDEB.html');">
        <td width="130" align="right">
            06:00AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2025/04/29/3069976/0/en/U-S-FDA-Approves-ZEVASKYN-prademagene-zamikeracel-the-First-and-Only-Cell-Based-Gene-Therapy-for-Patients-with-Recessive-Dystrophic-Epidermolysis-Bullosa-RDEB.html" target="_blank" rel="nofollow">U.S. FDA Approves ZEVASKYN (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Seeking Alpha', 'https://seekingalpha.com/article/4778317-undercovered-dozen-3d-systems-seritage-topicus-timken-plus?utm_source=finviz.com\u0026utm_medium=referral\u0026feed_item_type=article');">
        <td width="130" align="right">
            Apr-27-25 08:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://seekingalpha.com/article/4778317-undercovered-dozen-3d-systems-seritage-topicus-timken-plus?utm_source=finviz.com&amp;utm_medium=referral&amp;feed_item_type=article" target="_blank" rel="nofollow">Undercovered Dozen: 3D Systems, Seritage, Topicus, Timken +</a>
                </div>
                <div class="news-link-right">
                    <span>(Seeking Alpha)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Seeking Alpha', 'https://seekingalpha.com/article/4776153-pz-cel-has-massive-potential-for-rdeb-patients?utm_source=finviz.com\u0026utm_medium=referral\u0026feed_item_type=article');">
        <td width="130" align="right">
            Apr-21-25 10:00AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://seekingalpha.com/article/4776153-pz-cel-has-massive-potential-for-rdeb-patients?utm_source=finviz.com&amp;utm_medium=referral&amp;feed_item_type=article" target="_blank" rel="nofollow">Pz-Cel Has Massive Potential For RDEB Patients</a>
                </div>
                <div class="news-link-right">
                    <span>(Seeking Alpha)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Seeking Alpha', 'https://seekingalpha.com/article/4774935-abeona-therapeutics-uncertain-pivotal-regulatory-catalyst-limited-long-term-upside?utm_source=finviz.com\u0026utm_medium=referral\u0026feed_item_type=article');">
        <td width="130" align="right">
            Apr-14-25 07:11AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://seekingalpha.com/article/4774935-abeona-therapeutics-uncertain-pivotal-regulatory-catalyst-limited-long-term-upside?utm_source=finviz.com&amp;utm_medium=referral&amp;feed_item_type=article" target="_blank" rel="nofollow">Abeona Therapeutics: An Uncertain Pivotal Regulatory Catalyst With Limited Long-Term Upside</a>
                </div>
                <div class="news-link-right">
                    <span>(Seeking Alpha)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +7.61%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Seeking Alpha', 'https://seekingalpha.com/article/4774726-abeona-therapeutics-a-buy-with-major-pdufa-catalyst-on-april-29-that-should-send-shares-higher?utm_source=finviz.com\u0026utm_medium=referral\u0026feed_item_type=article');">
        <td width="130" align="right">
            Apr-12-25 11:39AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://seekingalpha.com/article/4774726-abeona-therapeutics-a-buy-with-major-pdufa-catalyst-on-april-29-that-should-send-shares-higher?utm_source=finviz.com&amp;utm_medium=referral&amp;feed_item_type=article" target="_blank" rel="nofollow">Abeona Therapeutics: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher</a>
                </div>
                <div class="news-link-right">
                    <span>(Seeking Alpha)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Seeking Alpha', 'https://seekingalpha.com/article/4773276-krystal-biotech-some-uncertainty-some-value?utm_source=finviz.com\u0026utm_medium=referral\u0026feed_item_type=article');">
        <td width="130" align="right">
            Apr-06-25 08:38AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://seekingalpha.com/article/4773276-krystal-biotech-some-uncertainty-some-value?utm_source=finviz.com&amp;utm_medium=referral&amp;feed_item_type=article" target="_blank" rel="nofollow">Krystal Biotech: Some Uncertainty, Some Value</a>
                </div>
                <div class="news-link-right">
                    <span>(Seeking Alpha)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2025/04/01/3053210/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Apr-01-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2025/04/01/3053210/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-loss is-negative-200"> -6.51%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GuruFocus.com', 'https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-q4-070215920.html');">
        <td width="130" align="right">
            Mar-21-25 03:02AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-q4-070215920.html" target="_blank" rel="nofollow">Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...</a>
                </div>
                <div class="news-link-right">
                    <span>(GuruFocus.com)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Thomson Reuters StreetEvents', 'https://finance.yahoo.com/news/q4-2024-abeona-therapeutics-inc-044140247.html');">
        <td width="130" align="right">
            12:41AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/q4-2024-abeona-therapeutics-inc-044140247.html" target="_blank" rel="nofollow">Q4 2024 Abeona Therapeutics Inc Earnings Call</a>
                </div>
                <div class="news-link-right">
                    <span>(Thomson Reuters StreetEvents)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'SeekingAlpha', 'https://seekingalpha.com/news/4423064-abeona-therapeutics-targets-2b-revenue-potential-for-pz-cel-amid-u-s-launch-preparations?utm_source=finviz.com\u0026utm_medium=referral\u0026feed_item_type=news');">
        <td width="130" align="right">
            Mar-20-25 03:21PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://seekingalpha.com/news/4423064-abeona-therapeutics-targets-2b-revenue-potential-for-pz-cel-amid-u-s-launch-preparations?utm_source=finviz.com&amp;utm_medium=referral&amp;feed_item_type=news" target="_blank" rel="nofollow">Abeona Therapeutics targets $2B revenue potential for pz-cel amid U.S. launch preparations</a>
                </div>
                <div class="news-link-right">
                    <span>(SeekingAlpha)</span></div></div></td></tr>

                        <tr>
                            <td width="130" align="right">03:20PM</td>
                            <td align="left" id="IC_D_3x8_3"><span class="block text-2xs text-gray-500 leading-none">Loading…</span></td>
                        </tr>
                      <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'SeekingAlpha', 'https://seekingalpha.com/article/4769216-abeona-therapeutics-inc-abeo-q4-2024-earnings-call-transcript?utm_source=finviz.com\u0026utm_medium=referral\u0026feed_item_type=transcript');">
        <td width="130" align="right">
            03:20PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://seekingalpha.com/article/4769216-abeona-therapeutics-inc-abeo-q4-2024-earnings-call-transcript?utm_source=finviz.com&amp;utm_medium=referral&amp;feed_item_type=transcript" target="_blank" rel="nofollow">Abeona Therapeutics Inc. (ABEO) Q4 2024 Earnings Call Transcript</a>
                </div>
                <div class="news-link-right">
                    <span>(SeekingAlpha)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2025/03/20/3046122/0/en/Abeona-Therapeutics-Reports-Full-Year-2024-Financial-Results-Provides-Pz-cel-Regulatory-Update-and-Commercial-Launch-Plans.html');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2025/03/20/3046122/0/en/Abeona-Therapeutics-Reports-Full-Year-2024-Financial-Results-Provides-Pz-cel-Regulatory-Update-and-Commercial-Launch-Plans.html" target="_blank" rel="nofollow">Abeona Therapeutics Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2025/03/04/3036603/0/en/Abeona-Therapeutics-to-Present-at-the-Leerink-Partners-Global-Healthcare-Conference.html');">
        <td width="130" align="right">
            Mar-04-25 09:00AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2025/03/04/3036603/0/en/Abeona-Therapeutics-to-Present-at-the-Leerink-Partners-Global-Healthcare-Conference.html" target="_blank" rel="nofollow">Abeona Therapeutics to Present at the Leerink Partners Global Healthcare Conference</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'TipRanks', 'https://finance.yahoo.com/news/abeona-therapeutics-announces-employee-inducement-124607696.html');">
        <td width="130" align="right">
            07:46AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-announces-employee-inducement-124607696.html" target="_blank" rel="nofollow">Abeona Therapeutics announces new employee inducement grants</a>
                </div>
                <div class="news-link-right">
                    <span>(TipRanks)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2025/03/03/3035522/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Mar-03-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2025/03/03/3035522/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2025/02/03/3019421/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Feb-03-25 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2025/02/03/3019421/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/12/31/3003095/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Dec-31-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/12/31/3003095/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/12/02/2989704/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Dec-02-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/12/02/2989704/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics  Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'ACCESS Newswire', 'https://finance.yahoo.com/news/dealflow-events-unveils-first-wave-120000736.html');">
        <td width="130" align="right">
            Nov-27-24 07:00AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/dealflow-events-unveils-first-wave-120000736.html" target="_blank" rel="nofollow">DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025</a>
                </div>
                <div class="news-link-right">
                    <span>(ACCESS Newswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +6.30%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GuruFocus.com', 'https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-q3-070656208.html');">
        <td width="130" align="right">
            Nov-15-24 02:06AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-q3-070656208.html" target="_blank" rel="nofollow">Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...</a>
                </div>
                <div class="news-link-right">
                    <span>(GuruFocus.com)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Associated Press Finance', 'https://finance.yahoo.com/news/abeona-therapeutics-q3-earnings-snapshot-124238029.html');">
        <td width="130" align="right">
            Nov-14-24 07:42AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-q3-earnings-snapshot-124238029.html" target="_blank" rel="nofollow">Abeona Therapeutics: Q3 Earnings Snapshot</a>
                </div>
                <div class="news-link-right">
                    <span>(Associated Press Finance)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/11/14/2981059/0/en/Abeona-Therapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Recent-Corporate-Updates.html');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/11/14/2981059/0/en/Abeona-Therapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Recent-Corporate-Updates.html" target="_blank" rel="nofollow">Abeona Therapeutics  Reports Third Quarter 2024 Financial Results and Recent Corporate Updates</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/11/12/2978973/0/en/Abeona-Therapeutics-Announces-FDA-Acceptance-of-BLA-Resubmission-of-Pz-cel-for-the-Treatment-of-Recessive-Dystrophic-Epidermolysis-Bullosa.html');">
        <td width="130" align="right">
            Nov-12-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/11/12/2978973/0/en/Abeona-Therapeutics-Announces-FDA-Acceptance-of-BLA-Resubmission-of-Pz-cel-for-the-Treatment-of-Recessive-Dystrophic-Epidermolysis-Bullosa.html" target="_blank" rel="nofollow">Abeona Therapeutics  Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-loss is-negative-200"> -5.05%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/11/04/2973948/0/en/Abeona-Therapeutics-Announces-Participation-in-November-Investor-Conferences.html');">
        <td width="130" align="right">
            Nov-04-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/11/04/2973948/0/en/Abeona-Therapeutics-Announces-Participation-in-November-Investor-Conferences.html" target="_blank" rel="nofollow">Abeona Therapeutics  Announces Participation in November Investor Conferences</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/11/01/2973289/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Nov-01-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/11/01/2973289/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics  Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/10/29/2970698/0/en/Abeona-Therapeutics-Completes-Pz-cel-Biologics-License-Application-Resubmission-to-U-S-Food-and-Drug-Administration.html');">
        <td width="130" align="right">
            Oct-29-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/10/29/2970698/0/en/Abeona-Therapeutics-Completes-Pz-cel-Biologics-License-Application-Resubmission-to-U-S-Food-and-Drug-Administration.html" target="_blank" rel="nofollow">Abeona Therapeutics  Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GuruFocus.com', 'https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-q2-221328134.html');">
        <td width="130" align="right">
            Oct-09-24 06:13PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-q2-221328134.html" target="_blank" rel="nofollow">Abeona Therapeutics Inc (ABEO) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...</a>
                </div>
                <div class="news-link-right">
                    <span>(GuruFocus.com)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/10/01/2955999/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Oct-01-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/10/01/2955999/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics  Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/09/03/2939572/0/en/Abeona-Therapeutics-Announces-Participation-in-Upcoming-Investor-Conferences.html');">
        <td width="130" align="right">
            Sep-03-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/09/03/2939572/0/en/Abeona-Therapeutics-Announces-Participation-in-Upcoming-Investor-Conferences.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces Participation in Upcoming Investor Conferences</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/09/02/2939023/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Sep-02-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/09/02/2939023/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics  Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/08/14/2929959/0/en/Abeona-Therapeutics-Announces-Appointment-of-Bernhardt-Zeiher-MD-FCCP-FACP-and-Eric-Crombez-MD-to-its-Board-of-Directors.html');">
        <td width="130" align="right">
            Aug-14-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/08/14/2929959/0/en/Abeona-Therapeutics-Announces-Appointment-of-Bernhardt-Zeiher-MD-FCCP-FACP-and-Eric-Crombez-MD-to-its-Board-of-Directors.html" target="_blank" rel="nofollow">Abeona Therapeutics  Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/08/13/2929090/0/en/Abeona-Therapeutics-Announces-Favorable-Medicare-Reimbursement-Decisions-for-Pz-cel.html');">
        <td width="130" align="right">
            Aug-13-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/08/13/2929090/0/en/Abeona-Therapeutics-Announces-Favorable-Medicare-Reimbursement-Decisions-for-Pz-cel.html" target="_blank" rel="nofollow">Abeona Therapeutics  Announces Favorable Medicare Reimbursement Decisions for Pz-cel</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Associated Press Finance', 'https://finance.yahoo.com/news/abeona-therapeutics-q2-earnings-snapshot-113735777.html');">
        <td width="130" align="right">
            Aug-12-24 07:37AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-q2-earnings-snapshot-113735777.html" target="_blank" rel="nofollow">Abeona Therapeutics: Q2 Earnings Snapshot</a>
                </div>
                <div class="news-link-right">
                    <span>(Associated Press Finance)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +11.99%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/08/12/2928295/0/en/Abeona-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Concludes-Type-A-Meeting-with-FDA-to-Align-on-Upcoming-Pz-cel-BLA-Resubmission.html');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/08/12/2928295/0/en/Abeona-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Concludes-Type-A-Meeting-with-FDA-to-Align-on-Upcoming-Pz-cel-BLA-Resubmission.html" target="_blank" rel="nofollow">Abeona Therapeutics  Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/08/01/2922672/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Aug-01-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/08/01/2922672/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics  Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/07/11/2911728/0/en/Abeona-Therapeutics-and-Beacon-Therapeutics-Announce-Non-Exclusive-Agreement-for-Beacon-to-Evaluate-Therapeutic-Potential-of-Abeona-s-Patented-AAV204-Capsid-for-Select-Ophthalmolog.html');">
        <td width="130" align="right">
            Jul-11-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/07/11/2911728/0/en/Abeona-Therapeutics-and-Beacon-Therapeutics-Announce-Non-Exclusive-Agreement-for-Beacon-to-Evaluate-Therapeutic-Potential-of-Abeona-s-Patented-AAV204-Capsid-for-Select-Ophthalmolog.html" target="_blank" rel="nofollow">Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/07/08/2909532/0/en/Abeona-Therapeutics-to-Present-at-the-Stifel-Virtual-Cell-Therapy-Forum.html');">
        <td width="130" align="right">
            Jul-08-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/07/08/2909532/0/en/Abeona-Therapeutics-to-Present-at-the-Stifel-Virtual-Cell-Therapy-Forum.html" target="_blank" rel="nofollow">Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +5.73%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GuruFocus.com', 'https://finance.yahoo.com/news/insider-sale-director-christine-silverstein-070832295.html');">
        <td width="130" align="right">
            Jun-21-24 03:08AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/insider-sale-director-christine-silverstein-070832295.html" target="_blank" rel="nofollow">Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)</a>
                </div>
                <div class="news-link-right">
                    <span>(GuruFocus.com)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/06/03/2892138/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Jun-03-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/06/03/2892138/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/05/28/2888920/0/en/Abeona-Therapeutics-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html');">
        <td width="130" align="right">
            May-28-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/05/28/2888920/0/en/Abeona-Therapeutics-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html" target="_blank" rel="nofollow">Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GuruFocus.com', 'https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-q1-070156570.html');">
        <td width="130" align="right">
            May-16-24 03:01AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-q1-070156570.html" target="_blank" rel="nofollow">Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...</a>
                </div>
                <div class="news-link-right">
                    <span>(GuruFocus.com)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Thomson Reuters StreetEvents', 'https://finance.yahoo.com/news/q1-2024-abeona-therapeutics-inc-061710938.html');">
        <td width="130" align="right">
            02:17AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/q1-2024-abeona-therapeutics-inc-061710938.html" target="_blank" rel="nofollow">Q1 2024 Abeona Therapeutics Inc Earnings Call</a>
                </div>
                <div class="news-link-right">
                    <span>(Thomson Reuters StreetEvents)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'InvestorPlace', 'https://investorplace.com/earning-results/2024/05/abeo-stock-earnings-abeona-therapeutics-for-q1-of-2024/');">
        <td width="130" align="right">
            May-15-24 12:53PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://investorplace.com/earning-results/2024/05/abeo-stock-earnings-abeona-therapeutics-for-q1-of-2024/" target="_blank" rel="nofollow">ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024</a>
                </div>
                <div class="news-link-right">
                    <span>(InvestorPlace)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +12.14%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Associated Press Finance', 'https://finance.yahoo.com/news/abeona-therapeutics-q1-earnings-snapshot-114345327.html');">
        <td width="130" align="right">
            07:43AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-q1-earnings-snapshot-114345327.html" target="_blank" rel="nofollow">Abeona Therapeutics: Q1 Earnings Snapshot</a>
                </div>
                <div class="news-link-right">
                    <span>(Associated Press Finance)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/05/15/2882305/0/en/Abeona-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Recent-Corporate-Progress.html');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/05/15/2882305/0/en/Abeona-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Recent-Corporate-Progress.html" target="_blank" rel="nofollow">Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/05/07/2876617/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            May-07-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/05/07/2876617/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'MT Newswires', 'https://finance.yahoo.com/news/abeona-therapeutics-prices-75-million-151947743.html');">
        <td width="130" align="right">
            May-03-24 11:19AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-prices-75-million-151947743.html" target="_blank" rel="nofollow">Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise</a>
                </div>
                <div class="news-link-right">
                    <span>(MT Newswires)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +13.02%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/05/03/2875048/0/en/Abeona-Therapeutics-Announces-Pricing-of-75-Million-Underwritten-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/05/03/2875048/0/en/Abeona-Therapeutics-Announces-Pricing-of-75-Million-Underwritten-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'MT Newswires', 'https://finance.yahoo.com/news/top-midday-decliners-180449113.html');">
        <td width="130" align="right">
            Apr-23-24 02:04PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/top-midday-decliners-180449113.html" target="_blank" rel="nofollow">Top Midday Decliners</a>
                </div>
                <div class="news-link-right">
                    <span>(MT Newswires)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-loss is-negative-200"> -53.67%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'InvestorPlace', 'https://investorplace.com/2024/04/why-is-abeona-therapeutics-abeo-stock-down-45-today/');">
        <td width="130" align="right">
            08:53AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://investorplace.com/2024/04/why-is-abeona-therapeutics-abeo-stock-down-45-today/" target="_blank" rel="nofollow">Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?</a>
                </div>
                <div class="news-link-right">
                    <span>(InvestorPlace)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'MT Newswires', 'https://finance.yahoo.com/news/top-premarket-decliners-113931283.html');">
        <td width="130" align="right">
            07:39AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/top-premarket-decliners-113931283.html" target="_blank" rel="nofollow">Top Premarket Decliners</a>
                </div>
                <div class="news-link-right">
                    <span>(MT Newswires)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'BioPharma Dive', 'https://finance.yahoo.com/m/43243d91-ef97-3723-941a-caf4dc67b05a/fda-rejects-abeona-cell.html');">
        <td width="130" align="right">
            07:09AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/m/43243d91-ef97-3723-941a-caf4dc67b05a/fda-rejects-abeona-cell.html" target="_blank" rel="nofollow">FDA rejects Abeona cell therapy, asks for more manufacturing data</a>
                </div>
                <div class="news-link-right">
                    <span>(BioPharma Dive)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'MT Newswires', 'https://finance.yahoo.com/news/abeona-therapeutics-shares-slump-plans-215824186.html');">
        <td width="130" align="right">
            Apr-22-24 05:58PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-shares-slump-plans-215824186.html" target="_blank" rel="nofollow">Abeona Therapeutics Shares Slump After Plans to Reapply for Pz-cel Drug Approval</a>
                </div>
                <div class="news-link-right">
                    <span>(MT Newswires)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Reuters', 'https://finance.yahoo.com/news/1-us-fda-declines-approve-202742883.html');">
        <td width="130" align="right">
            04:27PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/1-us-fda-declines-approve-202742883.html" target="_blank" rel="nofollow">UPDATE 1-US FDA declines to approve Abeona's skin disorder treatment</a>
                </div>
                <div class="news-link-right">
                    <span>(Reuters)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Reuters', 'https://finance.yahoo.com/news/us-fda-declines-approve-abeonas-201409691.html');">
        <td width="130" align="right">
            04:14PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/us-fda-declines-approve-abeonas-201409691.html" target="_blank" rel="nofollow">US FDA declines to approve Abeona's skin disorder treatment</a>
                </div>
                <div class="news-link-right">
                    <span>(Reuters)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/04/22/2867205/0/en/Abeona-Therapeutics-Provides-Regulatory-Update-on-Pz-cel.html');">
        <td width="130" align="right">
            04:05PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/04/22/2867205/0/en/Abeona-Therapeutics-Provides-Regulatory-Update-on-Pz-cel.html" target="_blank" rel="nofollow">Abeona Therapeutics Provides Regulatory Update on Pz-cel</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/04/01/2855185/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Apr-01-24 08:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/04/01/2855185/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +6.48%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'InvestorPlace', 'https://investorplace.com/earning-results/2024/03/abeo-stock-earnings-abeona-therapeutics-for-q4-of-2023/');">
        <td width="130" align="right">
            Mar-19-24 06:53AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://investorplace.com/earning-results/2024/03/abeo-stock-earnings-abeona-therapeutics-for-q4-of-2023/" target="_blank" rel="nofollow">ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023</a>
                </div>
                <div class="news-link-right">
                    <span>(InvestorPlace)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +8.30%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GuruFocus.com', 'https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-reports-093112640.html');">
        <td width="130" align="right">
            05:31AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-reports-093112640.html" target="_blank" rel="nofollow">Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results</a>
                </div>
                <div class="news-link-right">
                    <span>(GuruFocus.com)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/03/18/2847702/0/en/Abeona-Therapeutics-Reports-Full-Year-2023-Financial-Results-and-Announces-Completion-of-FDA-Inspections.html');">
        <td width="130" align="right">
            Mar-18-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/03/18/2847702/0/en/Abeona-Therapeutics-Reports-Full-Year-2023-Financial-Results-and-Announces-Completion-of-FDA-Inspections.html" target="_blank" rel="nofollow">Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-loss is-negative-200"> -19.00%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/03/05/2840322/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Mar-05-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/03/05/2840322/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +8.32%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GuruFocus.com', 'https://finance.yahoo.com/news/steven-cohens-firm-increases-stake-105232827.html');">
        <td width="130" align="right">
            Feb-15-24 05:52AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/steven-cohens-firm-increases-stake-105232827.html" target="_blank" rel="nofollow">Steven Cohen's Firm Increases Stake in Abeona Therapeutics Inc</a>
                </div>
                <div class="news-link-right">
                    <span>(GuruFocus.com)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +5.53%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/02/01/2822431/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Feb-01-24 04:05PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/02/01/2822431/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +5.65%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/02/01/2821881/0/en/Abeona-Therapeutics-Announces-Progress-Update-on-Pz-cel-Biologics-License-Application-BLA.html');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/02/01/2821881/0/en/Abeona-Therapeutics-Announces-Progress-Update-on-Pz-cel-Biologics-License-Application-BLA.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2024/01/08/2805336/0/en/Abeona-Therapeutics-Announces-50-Million-Credit-Facility.html');">
        <td width="130" align="right">
            Jan-08-24 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2024/01/08/2805336/0/en/Abeona-Therapeutics-Announces-50-Million-Credit-Facility.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces $50 Million Credit Facility</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2023/12/15/2796994/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Dec-15-23 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2023/12/15/2796994/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2023/11/27/2786066/0/en/Abeona-Therapeutics-Announces-FDA-Accepts-and-Grants-Priority-Review-for-Pz-cel-Biologics-License-Application-BLA.html');">
        <td width="130" align="right">
            Nov-27-23 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2023/11/27/2786066/0/en/Abeona-Therapeutics-Announces-FDA-Accepts-and-Grants-Priority-Review-for-Pz-cel-Biologics-License-Application-BLA.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +11.60%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Insider Monkey', 'https://www.insidermonkey.com/blog/abeona-therapeutics-inc-nasdaqabeo-q3-2023-earnings-call-transcript-1225017/');">
        <td width="130" align="right">
            Nov-17-23 10:09AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.insidermonkey.com/blog/abeona-therapeutics-inc-nasdaqabeo-q3-2023-earnings-call-transcript-1225017/" target="_blank" rel="nofollow">Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript</a>
                </div>
                <div class="news-link-right">
                    <span>(Insider Monkey)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Thomson Reuters StreetEvents', 'https://finance.yahoo.com/news/q3-2023-abeona-therapeutics-inc-092923850.html');">
        <td width="130" align="right">
            Nov-14-23 04:29AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/q3-2023-abeona-therapeutics-inc-092923850.html" target="_blank" rel="nofollow">Q3 2023 Abeona Therapeutics Inc Earnings Call</a>
                </div>
                <div class="news-link-right">
                    <span>(Thomson Reuters StreetEvents)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-loss is-negative-200"> -5.56%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GuruFocus.com', 'https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-reports-172356111.html');">
        <td width="130" align="right">
            Nov-13-23 12:23PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-inc-abeo-reports-172356111.html" target="_blank" rel="nofollow">Abeona Therapeutics Inc (ABEO) Reports Q3 2023 Financial Results and Advances in Commercial ...</a>
                </div>
                <div class="news-link-right">
                    <span>(GuruFocus.com)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +10.02%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Associated Press Finance', 'https://finance.yahoo.com/news/abeona-therapeutics-q3-earnings-snapshot-124149142.html');">
        <td width="130" align="right">
            07:41AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-q3-earnings-snapshot-124149142.html" target="_blank" rel="nofollow">Abeona Therapeutics: Q3 Earnings Snapshot</a>
                </div>
                <div class="news-link-right">
                    <span>(Associated Press Finance)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2023/11/13/2778937/0/en/Abeona-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Corporate-Developments.html');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2023/11/13/2778937/0/en/Abeona-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Corporate-Developments.html" target="_blank" rel="nofollow">Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://www.globenewswire.com/news-release/2023/11/01/2771021/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html');">
        <td width="130" align="right">
            Nov-01-23 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://www.globenewswire.com/news-release/2023/11/01/2771021/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://finance.yahoo.com/news/abeona-therapeutics-submits-biologics-license-113000603.html');">
        <td width="130" align="right">
            Sep-26-23 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-submits-biologics-license-113000603.html" target="_blank" rel="nofollow">Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis Bullosa</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +9.84%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'InvestorPlace', 'https://finance.yahoo.com/news/3-biotech-blockbusters-turn-5-164804110.html');">
        <td width="130" align="right">
            Sep-12-23 12:48PM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/3-biotech-blockbusters-turn-5-164804110.html" target="_blank" rel="nofollow">3 Biotech Blockbusters to Turn $5,000 Into $50,000</a>
                </div>
                <div class="news-link-right">
                    <span>(InvestorPlace)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://finance.yahoo.com/news/abeona-therapeutics-appoints-madhav-vasanthavada-113000778.html');">
        <td width="130" align="right">
            07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-appoints-madhav-vasanthavada-113000778.html" target="_blank" rel="nofollow">Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://finance.yahoo.com/news/abeona-therapeutics-announces-participation-upcoming-113000679.html');">
        <td width="130" align="right">
            Sep-07-23 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-announces-participation-upcoming-113000679.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces Participation in Upcoming Investor Conferences</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'GlobeNewswire', 'https://finance.yahoo.com/news/abeona-therapeutics-announces-positive-pre-113000592.html');">
        <td width="130" align="right">
            Aug-30-23 07:30AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-announces-positive-pre-113000592.html" target="_blank" rel="nofollow">Abeona Therapeutics Announces Positive Pre-BLA Meeting with FDA for EB-101 and Plans for BLA Submission</a>
                </div>
                <div class="news-link-right">
                    <span>(GlobeNewswire)</span> <span class="fv-label flex items-center leading-none h-4 gap-1 body-table-news-gain is-positive-200"> +5.60%</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'Zacks', 'https://finance.yahoo.com/news/abeo-track-file-bla-3q23-114100883.html');">
        <td width="130" align="right">
            Aug-11-23 07:41AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeo-track-file-bla-3q23-114100883.html" target="_blank" rel="nofollow">ABEO: On Track to File BLA in 3Q23...</a>
                </div>
                <div class="news-link-right">
                    <span>(Zacks)</span></div></div></td></tr>
    <tr class="cursor-pointer has-label" onclick="trackAndOpenNews(event, 'AP Finance', 'https://finance.yahoo.com/news/abeona-therapeutics-q2-earnings-snapshot-122735359.html');">
        <td width="130" align="right">
            Aug-08-23 08:27AM
        </td>
        <td align="left">
            <div class="news-link-container">
                <div class="news-link-left">
                    <a class="tab-link-news" href="https://finance.yahoo.com/news/abeona-therapeutics-q2-earnings-snapshot-122735359.html" target="_blank" rel="nofollow">Abeona Therapeutics: Q2 Earnings Snapshot</a>
                </div>
                <div class="news-link-right">
                    <span>(AP Finance)</span></div></div></td></tr>
</tbody></table>
</div>
</td><td width="300" valign="top" style="padding-left: 10px"><div id="IC_D_300x250_1" class="relative overflow-hidden flex items-center justify-center w-full mx-auto" style="width:300px;height:250px;max-height:250px"></div><div id="stocktwits-widget-news" class="fullview-news-outer quote_stocktwits box-content w-[300px]" data-testid="quote-stocktwits-widget-news-container">
    <div class="quote_stocktwits-bottom-cover"></div>
    <div class="quote_stocktwits-right-cover"></div>
<iframe allowtranparency="true" frameborder="0" border="0" style="border: 0px; width: 300px; height: 1766px;" scrolling="no"></iframe></div>
<script type="text/javascript">
    function StocktwitsInit() {
        var StocktwitsHeight = document.getElementById('news-table').clientHeight - 500;
        if(typeof STWT !== 'undefined') {
            var isNewLayout = true;
            var isDarkTheme = true;
            var MIN_TWIT_HEIGHT = 71;
            var quoteTicker = 'ABEO';
            var bgColor = isNewLayout ? (isDarkTheme ? '22262F' : 'FFFFFF') : 'transparent';
            var text_color = isNewLayout ? (isDarkTheme ? 'C3C6D0' : '4C5263') : '000000';
            var link_color = isNewLayout ? (isDarkTheme ? '57aefb' : '306DCA') : '4871a8';
            var divider_color = isNewLayout ? (isDarkTheme ? '353945' : 'DEDFE5') : 'd3d3d3';
            var time_color = isNewLayout ? '868EA5' : '999999';
            var username_color = isNewLayout ? (isDarkTheme ? 'F3F3F5' : '22262F') : '600D0B';
            var font_size = isNewLayout ? 12 : 11;
            STWT.Widget({
                container: 'stocktwits-widget-news',
                symbol: quoteTicker,
                width: '300',
                height: StocktwitsHeight,
                limit: Math.ceil(StocktwitsHeight / MIN_TWIT_HEIGHT),
                scrollbars: 0,
                header: 0,
                streaming: 'true',
                style: { link_color, link_hover_color: link_color, header_text_color: text_color, border_color: bgColor, border_color_2: bgColor, divider_color, divider_type: 'solid', box_color: bgColor, stream_color: bgColor, text_color, time_color, font: 'Verdana, Arial, Tahoma', font_size, time_font_size: 10, username_font: 'Verdana, Arial, Tahoma', username_size: font_size, username_color, username_hover_color: username_color }
            });
        }
    }

    function loadStocktwitsScript() {
        var s = document.createElement('script');
        s.addEventListener('load', StocktwitsInit)
        s.setAttribute('async', true)
        s.src = '//api.stocktwits.com/addon/widget/2/widget-loader.min.js'
        document.body.appendChild(s)
    }

    if (document.readyState != 'loading'){
        loadStocktwitsScript();
    } else {
        document.addEventListener('DOMContentLoaded', loadStocktwitsScript);
    }
</script><div id="IC_D_300x250_2" class="relative overflow-hidden flex items-center justify-center w-full mx-auto" style="width:300px;height:250px;max-height:250px"></div></td></tr></tbody></table></td>
</tr>
<tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px" width="2" height="2"></td></tr>
<tr><td><table cellspacing="0" cellpading="0" border="0" width="100%" class="h-px">
<tbody><tr class="table-light3-row" height="1px">
<td class="fullview-profile quote_profile" align="left" valign="top"><div class="quote_profile-bio">Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.</div></td><td width="8"><img src="gfx/nic2x2.gif" style="width:8px;height:1px"></td><td class="fullview-profile quote_profile" align="left" valign="top" width="302" style="max-width: 302px;padding: 0;"><div class="managers-and-funds h-full"><div class="h-full space-y-2 rounded-md border border-primary py-2"><div class="flex w-full items-center justify-between px-2"><h4 class="m-0 text-2xs text-gray-400 font-normal font-bold leading-[1.375]">Institutional Ownership</h4><div class="flex items-center space-x-0.5"><button class="group/button flex items-center justify-center font-medium focus:outline-none border dark:disabled:hover:bg-transparent disabled:hover:bg-transparent dark:disabled:hover:text-gray-400 disabled:hover:text-gray-500 border-blue-400 bg-blue-50 text-gray-900 dark:bg-gray-500/30 dark:text-white px-1.5 text-2xs h-6 min-w-6 rounded-md shrink-0 whitespace-nowrap focus-visible:ring-2 ring-gray-200 dark:ring-gray-500 !text-default"><span class="grow text-center">Managers</span></button><button class="group/button flex items-center justify-center font-medium focus:outline-none border dark:disabled:hover:bg-transparent disabled:hover:bg-transparent dark:disabled:hover:text-gray-400 disabled:hover:text-gray-500 border-transparent text-gray-500 hover:bg-gray-200/30 hover:text-gray-900 dark:text-gray-400 dark:hover:bg-gray-500/30 dark:hover:text-gray-200 px-1.5 text-2xs h-6 min-w-6 rounded-md shrink-0 whitespace-nowrap focus-visible:ring-2 ring-gray-200 dark:ring-gray-500 !text-muted-2"><span class="grow text-center">Funds</span></button></div></div><div class="mx-2.5 h-0 border-t border-primary"></div><table class="styled-table-new table-fixed px-0.5 border-separate border-spacing-0 font-sans text-2xs tabular-nums text-gray-800 dark:text-gray-100 w-full" cellpadding="0"><tbody class=""><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=1569064">SUVRETTA CAPITAL MANAGEMENT, LLC</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">7.59%<span class="w-0 text-center"></span></span></td></tr><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=1472322">Nantahala Capital Management, LLC</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">7.23%<span class="w-0 text-center"></span></span></td></tr><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=1165408">ADAGE CAPITAL PARTNERS GP, L.L.C.</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">5.55%<span class="w-0 text-center"></span></span></td></tr><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=1517666">Western Standard LLC</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">4.70%<span class="w-0 text-center"></span></span></td></tr><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=102909">VANGUARD GROUP INC</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">4.16%<span class="w-0 text-center"></span></span></td></tr><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=1674712">Vivo Capital, LLC</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">3.80%<span class="w-0 text-center"></span></span></td></tr><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=1622627">Rosalind Advisors, Inc.</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">3.72%<span class="w-0 text-center"></span></span></td></tr><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=1390202">Laurion Capital Management LP</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">2.69%<span class="w-0 text-center"></span></span></td></tr><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=1273087">MILLENNIUM MANAGEMENT LLC</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">1.67%<span class="w-0 text-center"></span></span></td></tr><tr class="group is-hoverable"><td class="p-0 leading-tight"><a class="tab-link block truncate" href="/insidertrading.ashx?view=manager-details&amp;investorId=1446194">SUSQUEHANNA INTERNATIONAL GROUP, LLP</a></td><td class="w-18 px-1 leading-tight text-right"><span class="w-full items-baseline justify-end whitespace-nowrap text-positive text-muted-2">1.57%<span class="w-0 text-center"></span></span></td></tr></tbody></table></div></div>
</td>
<script id="institutional-ownership-init-data-0" type="application/json">{"managersOwnership":[{"investorId":"1569064","name":"SUVRETTA CAPITAL MANAGEMENT, LLC","percOwnership":7.593683165134401},{"investorId":"1472322","name":"Nantahala Capital Management, LLC","percOwnership":7.23176425501403},{"investorId":"1165408","name":"ADAGE CAPITAL PARTNERS GP, L.L.C.","percOwnership":5.5458834873840495},{"investorId":"1517666","name":"Western Standard LLC","percOwnership":4.700227470340257},{"investorId":"102909","name":"VANGUARD GROUP INC","percOwnership":4.16242907005015},{"investorId":"1674712","name":"Vivo Capital, LLC","percOwnership":3.796840552357326},{"investorId":"1622627","name":"Rosalind Advisors, Inc.","percOwnership":3.7207410093584263},{"investorId":"1390202","name":"Laurion Capital Management LP","percOwnership":2.6921217790488274},{"investorId":"1273087","name":"MILLENNIUM MANAGEMENT LLC","percOwnership":1.6688699421846216},{"investorId":"1446194","name":"SUSQUEHANNA INTERNATIONAL GROUP, LLP","percOwnership":1.568119537312141}],"fundsOwnership":[{"investorId":"S000076483","name":"iShares Neuroscience and Healthcare ETF","percOwnership":0.006276652206254521}]}</script></tr>
</tbody></table>
</td>
</tr>
<tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px" width="2" height="2"></td></tr>
<tr><td width="100%"><div id="statements"><table width="100%" cellpadding="3" class="statements-table-header"><tbody><tr><td><span class="fullview-links"><a href="#" class="tab-link font-semibold">Income Statement</a> <span class="text-muted-3">•</span> <a href="#" class="tab-link">Balance Sheet</a> <span class="text-muted-3">•</span> <a href="#" class="tab-link">Cash Flow</a></span></td><td align="right"><div class="flex justify-end"><div class="flex flex-row space-x-5"><div class="flex items-center space-x-0.5"><p class="pr-1 text-disabled font-medium text-2xs">Data</p><button class="group/button flex items-center justify-center font-medium focus:outline-none border dark:disabled:hover:bg-transparent disabled:hover:bg-transparent dark:disabled:hover:text-gray-400 disabled:hover:text-gray-500 border-transparent text-gray-500 hover:bg-gray-200/30 hover:text-gray-900 dark:text-gray-400 dark:hover:bg-gray-500/30 dark:hover:text-gray-200 px-1.5 text-2xs h-6 min-w-6 rounded-md shrink-0 whitespace-nowrap focus-visible:ring-2 ring-gray-200 dark:ring-gray-500 !text-muted-2"><span class="grow text-center">YoY Growth </span></button><button class="group/button flex items-center justify-center font-medium focus:outline-none border dark:disabled:hover:bg-transparent disabled:hover:bg-transparent dark:disabled:hover:text-gray-400 disabled:hover:text-gray-500 border-transparent text-gray-500 hover:bg-gray-200/30 hover:text-gray-900 dark:text-gray-400 dark:hover:bg-gray-500/30 dark:hover:text-gray-200 px-1.5 text-2xs h-6 min-w-6 rounded-md shrink-0 whitespace-nowrap focus-visible:ring-2 ring-gray-200 dark:ring-gray-500 !text-muted-2"><span class="grow text-center">YoY Growth %</span></button></div><div class="flex items-center space-x-0.5"><p class="pr-1 text-disabled font-medium text-2xs">Timeframe</p><button class="group/button flex items-center justify-center font-medium focus:outline-none border dark:disabled:hover:bg-transparent disabled:hover:bg-transparent dark:disabled:hover:text-gray-400 disabled:hover:text-gray-500 border-blue-400 bg-blue-50 text-gray-900 dark:bg-gray-500/30 dark:text-white px-1.5 text-2xs h-6 min-w-6 rounded-md shrink-0 whitespace-nowrap focus-visible:ring-2 ring-gray-200 dark:ring-gray-500 !text-default"><span class="grow text-center">Annual</span></button><button class="group/button flex items-center justify-center font-medium focus:outline-none border dark:disabled:hover:bg-transparent disabled:hover:bg-transparent dark:disabled:hover:text-gray-400 disabled:hover:text-gray-500 border-transparent text-gray-500 hover:bg-gray-200/30 hover:text-gray-900 dark:text-gray-400 dark:hover:bg-gray-500/30 dark:hover:text-gray-200 px-1.5 text-2xs h-6 min-w-6 rounded-md shrink-0 whitespace-nowrap focus-visible:ring-2 ring-gray-200 dark:ring-gray-500 !text-muted-2"><span class="grow text-center">Quarterly</span></button></div></div></div></td></tr></tbody></table><table width="100%" cellpadding="3" cellspacing="0" data-testid="quote-statements-table" class="styled-table-new is-rounded quote_statements-table is-tabular-nums is-free"><tbody><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders is-highlighted first-row"><td class="align-top">Period</td><td class="align-top" align="center"></td><td align="right" class="align-top"><span class="">TTM</span></td><td align="right" class="align-top"><span class="">FY 2024</span></td><td align="right" class="align-top"><span class="">FY 2023</span></td><td align="right" class="align-top"><span class="">FY 2022</span></td><td align="right" class="align-top"><span class="">FY 2021</span></td><td align="right" class="align-top"><span class="">FY 2020</span></td><td align="right" class="align-top"><span class="">FY 2019</span></td><td align="right" class="align-top"><span class="">FY 2018</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Period End Date</td><td class="align-top" align="center"></td><td align="right" class="align-top"><span class="text-muted-2">—</span></td><td align="right" class="align-top"><span class="">12/31/2024</span></td><td align="right" class="align-top"><span class="">12/31/2023</span></td><td align="right" class="align-top"><span class="">12/31/2022</span></td><td align="right" class="align-top"><span class="">12/31/2021</span></td><td align="right" class="align-top"><span class="">12/31/2020</span></td><td align="right" class="align-top"><span class="">12/31/2019</span></td><td align="right" class="align-top"><span class="">12/31/2018</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders elite-row"><td class="align-top">Period Length</td><td class="align-top" align="center"></td><td align="right" class="align-top"><span class="">12 Months</span></td><td align="right" class="align-top"><span class="">12 Months</span></td><td align="right" class="align-top"><span class="">12 Months</span></td><td align="right" class="quote-statements-elite-subscribe align-middle" rowspan="30" colspan="6"><div class="mx-auto -mt-32 mb-15 text-center text-2xs text-blue-500" id="IC_D_300x60_1" style="width: 300px; min-height: 60px;"></div><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p class="quote-statements-elite-subscribe_text">Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders is-highlighted"><td class="align-top">Total Revenue</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="14.656" height="1.3439999999999994" width="3"></rect><rect class="bar bar--positive" x="4" y="11.2" height="4.800000000000001" width="3"></rect><rect class="bar bar--positive" x="8" y="16" height="0" width="3"></rect><rect class="bar bar--positive" x="12" y="0" height="16" width="3"></rect><rect class="bar bar--positive" x="16" y="11.2" height="4.800000000000001" width="3"></rect><rect class="bar bar--positive" x="20" y="13.744" height="2.2560000000000002" width="3"></rect><rect class="bar bar--positive" x="24" y="10.4" height="5.6" width="3"></rect><rect class="bar bar--positive" x="28" y="16" height="0" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r2»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">0.00</span></td><td align="right" class="align-top"><span class="">0.00</span></td><td align="right" class="align-top"><span class="">3.50</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Cost of Goods Sold Incl. D&amp;A</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="16" height="8" width="3"></rect><rect class="bar bar--positive" x="4" y="16" height="8" width="3"></rect><rect class="bar bar--positive" x="8" y="0.568888888888889" height="15.431111111111111" width="3"></rect><rect class="bar bar--positive" x="12" y="6.044444444444444" height="9.955555555555556" width="3"></rect><rect class="bar bar--positive" x="16" y="8.071111111111112" height="7.928888888888888" width="3"></rect><rect class="bar bar--positive" x="20" y="7.857777777777777" height="8.142222222222223" width="3"></rect><rect class="bar bar--positive" x="24" y="10.31111111111111" height="5.68888888888889" width="3"></rect><rect class="bar bar--positive" x="28" y="10.826666666666666" height="5.173333333333334" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r4»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">3.98</span></td><td align="right" class="align-top"><span class="">2.91</span></td><td align="right" class="align-top"><span class="">3.20</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders is-highlighted"><td class="align-top">Gross Profit</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="4" y="8" height="0" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="6.943999999999999" width="3"></rect><rect class="bar bar--positive" x="12" y="4.48" height="3.5199999999999996" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="1.168000000000001" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="2.5280000000000005" width="3"></rect><rect class="bar bar--positive" x="24" y="7.76" height="0.5" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="2.3279999999999994" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r6»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-3.98</span></td><td align="right" class="align-top"><span class="">-2.91</span></td><td align="right" class="align-top"><span class="">0.30</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Selling, General and Administrative Excl. Other</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="9.616" height="6.384" width="3"></rect><rect class="bar bar--positive" x="4" y="2.5600000000000005" height="13.44" width="3"></rect><rect class="bar bar--positive" x="8" y="0.36342857142857277" height="15.636571428571427" width="3"></rect><rect class="bar bar--positive" x="12" y="3.9085714285714293" height="12.09142857142857" width="3"></rect><rect class="bar bar--positive" x="16" y="3.2205714285714286" height="12.779428571428571" width="3"></rect><rect class="bar bar--positive" x="20" y="6.379428571428571" height="9.620571428571429" width="3"></rect><rect class="bar bar--positive" x="24" y="4.914285714285715" height="11.085714285714285" width="3"></rect><rect class="bar bar--positive" x="28" y="1.9885714285714293" height="14.01142857142857" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r8»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">65.63</span></td><td align="right" class="align-top"><span class="">61.30</span></td><td align="right" class="align-top"><span class="">48.50</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Research and Development</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="10.5632" height="5.4368" width="3"></rect><rect class="bar bar--positive" x="4" y="3.6159999999999997" height="12.384" width="3"></rect><rect class="bar bar--positive" x="8" y="0.45759999999999934" height="15.5424" width="3"></rect><rect class="bar bar--positive" x="12" y="6.3552" height="9.6448" width="3"></rect><rect class="bar bar--positive" x="16" y="5.0144" height="10.9856" width="3"></rect><rect class="bar bar--positive" x="20" y="6.732799999999999" height="9.2672" width="3"></rect><rect class="bar bar--positive" x="24" y="6.0512" height="9.9488" width="3"></rect><rect class="bar bar--positive" x="28" y="5.0047999999999995" height="10.9952" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«ra»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">37.09</span></td><td align="right" class="align-top"><span class="">34.36</span></td><td align="right" class="align-top"><span class="">31.09</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Other Operating Expense</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="4" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="8" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="12" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="16" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="20" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="24" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="28" y="8" height="0" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«rc»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">0.00</span></td><td align="right" class="align-top"><span class="">0.00</span></td><td align="right" class="align-top"><span class="">0.00</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders is-highlighted"><td class="align-top">Operating Income</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="2.7840000000000007" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="5.817" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="7.709" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="4.85" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="5.737" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="4.526" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="4.82" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="6.420999999999999" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«re»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-69.61</span></td><td align="right" class="align-top"><span class="">-64.21</span></td><td align="right" class="align-top"><span class="">-48.20</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Interest Expense</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="16" height="0" width="3"></rect><rect class="bar bar--positive" x="4" y="16" height="0" width="3"></rect><rect class="bar bar--positive" x="8" y="16" height="0" width="3"></rect><rect class="bar bar--positive" x="12" y="1.351111111111111" height="14.648888888888889" width="3"></rect><rect class="bar bar--positive" x="16" y="2.9511111111111106" height="13.04888888888889" width="3"></rect><rect class="bar bar--positive" x="20" y="13.36888888888889" height="2.6311111111111103" width="3"></rect><rect class="bar bar--positive" x="24" y="14.506666666666668" height="1.4933333333333323" width="3"></rect><rect class="bar bar--positive" x="28" y="1.0311111111111106" height="14.96888888888889" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«rg»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">4.25</span></td><td align="right" class="align-top"><span class="">4.21</span></td><td align="right" class="align-top"><span class="">0.42</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Unusual Expense</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="4" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="8" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="12" y="0.4754285714285711" height="7.524571428571429" width="3"></rect><rect class="bar bar--positive" x="16" y="2.523428571428571" height="5.476571428571429" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="1.30742857142857" width="3"></rect><rect class="bar bar--positive" x="24" y="5.805714285714286" height="2.194285714285714" width="3"></rect><rect class="bar bar--positive" x="28" y="7.826285714285715" height="0.5" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«ri»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-23.79</span></td><td align="right" class="align-top"><span class="">0.76</span></td><td align="right" class="align-top"><span class="">9.60</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders is-highlighted"><td class="align-top">Net Income Before Taxes</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="2.185599999999999" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="4.5336" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="6.102399999999999" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="6.7384" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="6.7951999999999995" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="3.176" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="4.3352" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="5.0984" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«rk»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-44.19</span></td><td align="right" class="align-top"><span class="">-63.73</span></td><td align="right" class="align-top"><span class="">-54.19</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Income Taxes</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="4" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="8" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="12" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="16" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="20" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="24" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="28" y="8" height="0" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«rm»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">0.00</span></td><td align="right" class="align-top"><span class="">0.00</span></td><td align="right" class="align-top"><span class="">0.00</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Consolidated Net Income</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="2.185599999999999" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="4.5336" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="6.102399999999999" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="6.7384" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="6.7951999999999995" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="3.176" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="4.3352" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="5.0984" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«ro»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-44.19</span></td><td align="right" class="align-top"><span class="">-63.73</span></td><td align="right" class="align-top"><span class="">-54.19</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Net Income From Continuing Operations</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="2.185599999999999" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="4.5336" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="6.102399999999999" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="6.7384" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="6.7951999999999995" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="3.176" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="4.3352" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="5.0984" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«rq»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-44.19</span></td><td align="right" class="align-top"><span class="">-63.73</span></td><td align="right" class="align-top"><span class="">-54.19</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders is-highlighted"><td class="align-top">Net Income</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="2.185599999999999" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="4.5336" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="6.102399999999999" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="6.7384" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="6.7951999999999995" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="3.4784000000000006" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="4.3352" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="5.0984" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«rs»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-44.19</span></td><td align="right" class="align-top"><span class="">-63.73</span></td><td align="right" class="align-top"><span class="">-54.19</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">EPS (Recurring)</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="3.2799999999999994" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="5.962" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="7.574" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="3.3019999999999996" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="3.4619999999999997" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="1.2080000000000002" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="0.5" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="0.5" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«ru»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-1.64</span></td><td align="right" class="align-top"><span class="">-1.54</span></td><td align="right" class="align-top"><span class="">-2.22</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">EPS (Basic, Before Extraordinaries)</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="3.3000000000000007" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="5.962" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="7.574" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="4.545999999999999" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="4.314" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="1.1059999999999999" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="0.5060000000000002" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="0.5" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r10»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-0.89</span></td><td align="right" class="align-top"><span class="">-1.55</span></td><td align="right" class="align-top"><span class="">-2.53</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">EPS (Diluted)</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="3.3000000000000007" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="5.962" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="7.574" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="4.545999999999999" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="4.314" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="1.1059999999999999" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="0.5060000000000002" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="0.5" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r12»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-1.34</span></td><td align="right" class="align-top"><span class="">-1.55</span></td><td align="right" class="align-top"><span class="">-2.53</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">EBITDA</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="3.096" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="6.378285714285715" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="7.8182857142857145" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="4.902857142857142" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="6.046857142857142" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="4.6491428571428575" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="5.142857142857142" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="7.005714285714285" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r14»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-65.63</span></td><td align="right" class="align-top"><span class="">-61.30</span></td><td align="right" class="align-top"><span class="">-45.00</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Non-Operating Income (Expense)</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="14.487272727272728" height="1.5127272727272718" width="3"></rect><rect class="bar bar--positive" x="4" y="11.636363636363637" height="4.363636363636363" width="3"></rect><rect class="bar bar--positive" x="8" y="13.643636363636364" height="2.3563636363636355" width="3"></rect><rect class="bar bar--positive" x="12" y="12.218181818181819" height="3.7818181818181813" width="3"></rect><rect class="bar bar--positive" x="16" y="15.796363636363637" height="0.5" width="3"></rect><rect class="bar bar--positive" x="20" y="14.341818181818182" height="1.6581818181818182" width="3"></rect><rect class="bar bar--positive" x="24" y="4.2763636363636355" height="11.723636363636365" width="3"></rect><rect class="bar bar--positive" x="28" y="0.1745454545454539" height="15.825454545454546" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r16»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">5.88</span></td><td align="right" class="align-top"><span class="">5.44</span></td><td align="right" class="align-top"><span class="">4.03</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Other After Tax Adjustments</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="4" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="8" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="12" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="16" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="20" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="24" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="28" y="8" height="0" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r18»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">0.00</span></td><td align="right" class="align-top"><span class="">0.00</span></td><td align="right" class="align-top"><span class="">0.00</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Stock Option Compensation Expense</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="7.751111111111111" height="8.248888888888889" width="3"></rect><rect class="bar bar--positive" x="4" y="1.4577777777777783" height="14.542222222222222" width="3"></rect><rect class="bar bar--positive" x="8" y="2.9511111111111106" height="13.04888888888889" width="3"></rect><rect class="bar bar--positive" x="12" y="1.4400000000000013" height="14.559999999999999" width="3"></rect><rect class="bar bar--positive" x="16" y="0.14222222222222314" height="15.857777777777777" width="3"></rect><rect class="bar bar--positive" x="20" y="10.57777777777778" height="5.422222222222221" width="3"></rect><rect class="bar bar--positive" x="24" y="7.520000000000001" height="8.479999999999999" width="3"></rect><rect class="bar bar--positive" x="28" y="4.213333333333333" height="11.786666666666667" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r1a»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">7.78</span></td><td align="right" class="align-top"><span class="">6.63</span></td><td align="right" class="align-top"><span class="">4.77</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders is-highlighted"><td class="align-top">Price To Earnings Ratio</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="7.309999999999999" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="3.629999999999999" width="3"></rect><rect class="bar bar--negative" x="8" y="8" height="1.5500000000000007" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="0.5600000000000005" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="0.5" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="2.5" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="2.08" width="3"></rect><rect class="bar bar--negative" x="28" y="8" height="4.879999999999999" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r1c»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">-4.88</span></td><td align="right" class="align-top"><span class="">-4.88</span></td><td align="right" class="align-top"><span class="">-2.08</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Price To Sales Ratio</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="0.23079999999999856" height="15.769200000000001" width="3"></rect><rect class="bar bar--positive" x="4" y="13.7362" height="2.2638" width="3"></rect><rect class="bar bar--positive" x="8" y="16" height="8" width="3"></rect><rect class="bar bar--positive" x="12" y="15.709" height="0.5" width="3"></rect><rect class="bar bar--positive" x="16" y="15.7788" height="0.5" width="3"></rect><rect class="bar bar--positive" x="20" y="15.6576" height="0.5" width="3"></rect><rect class="bar bar--positive" x="24" y="15.388" height="0.6120000000000001" width="3"></rect><rect class="bar bar--positive" x="28" y="16" height="8" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r1e»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="text-muted-2">—</span></td><td align="right" class="align-top"><span class="text-muted-2">—</span></td><td align="right" class="align-top"><span class="">30.60</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Gross Margin</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="4" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="8" y="8" height="0" width="3"></rect><rect class="bar bar--positive" x="12" y="6.592319999999999" height="1.407680000000001" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="1.5616000000000003" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="7.15808" width="3"></rect><rect class="bar bar--positive" x="24" y="7.723840000000001" height="0.5" width="3"></rect><rect class="bar bar--positive" x="28" y="8" height="0" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r1g»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="text-muted-2">—</span></td><td align="right" class="align-top"><span class="text-muted-2">—</span></td><td align="right" class="align-top"><span class="">8.63</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Operating Margin</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="7.601577142857144" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="4.434651428571428" width="3"></rect><rect class="bar bar--positive" x="8" y="8" height="0" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="1.108662857142857" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="4.371040000000001" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="7.315748571428571" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="3.147748571428572" width="3"></rect><rect class="bar bar--positive" x="28" y="8" height="0" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r1i»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="text-muted-2">—</span></td><td align="right" class="align-top"><span class="text-muted-2">—</span></td><td align="right" class="align-top"><span class="">-1,377.14</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Net Margin</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--negative" x="0" y="8" height="7.460388571428572" width="3"></rect><rect class="bar bar--negative" x="4" y="8" height="4.320662857142857" width="3"></rect><rect class="bar bar--positive" x="8" y="8" height="0" width="3"></rect><rect class="bar bar--negative" x="12" y="8" height="1.9253485714285716" width="3"></rect><rect class="bar bar--negative" x="16" y="8" height="6.471314285714286" width="3"></rect><rect class="bar bar--negative" x="20" y="8" height="7.02816" width="3"></rect><rect class="bar bar--negative" x="24" y="8" height="3.538811428571428" width="3"></rect><rect class="bar bar--positive" x="28" y="8" height="0" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r1k»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="text-muted-2">—</span></td><td align="right" class="align-top"><span class="text-muted-2">—</span></td><td align="right" class="align-top"><span class="">-1,548.23</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Shares Outstanding</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="15.3984" height="0.6015999999999995" width="3"></rect><rect class="bar bar--positive" x="4" y="15.3856" height="0.6143999999999998" width="3"></rect><rect class="bar bar--positive" x="8" y="14.9312" height="1.0687999999999995" width="3"></rect><rect class="bar bar--positive" x="12" y="14.768" height="1.2319999999999993" width="3"></rect><rect class="bar bar--positive" x="16" y="14.1152" height="1.8848000000000003" width="3"></rect><rect class="bar bar--positive" x="20" y="10.3296" height="5.670400000000001" width="3"></rect><rect class="bar bar--positive" x="24" y="7.5136" height="8.4864" width="3"></rect><rect class="bar bar--positive" x="28" y="1.395199999999999" height="14.604800000000001" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r1m»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">48.95</span></td><td align="right" class="align-top"><span class="">45.64</span></td><td align="right" class="align-top"><span class="">26.52</span></td></tr><tr class="styled-row is-hoverable is-bordered is-rounded is-border-top is-hover-borders"><td class="align-top">Market Capitalization</td><td class="align-top" align="center"><div class="tooltip"><div tabindex="0"><svg class="quote-bar-chart" style="width: 32px; height: 16px;"><rect class="bar bar--positive" x="0" y="0.6139428571428578" height="15.386057142857142" width="3"></rect><rect class="bar bar--positive" x="4" y="7.854628571428572" height="8.145371428571428" width="3"></rect><rect class="bar bar--positive" x="8" y="9.779657142857143" height="6.220342857142857" width="3"></rect><rect class="bar bar--positive" x="12" y="14.512457142857143" height="1.4875428571428575" width="3"></rect><rect class="bar bar--positive" x="16" y="13.581714285714286" height="2.418285714285714" width="3"></rect><rect class="bar bar--positive" x="20" y="10.3264" height="5.6736" width="3"></rect><rect class="bar bar--positive" x="24" y="4.8516571428571424" height="11.148342857142858" width="3"></rect><rect class="bar bar--positive" x="28" y="0.7291428571428558" height="15.270857142857144" width="3"></rect></svg></div><div style="position: absolute; top: 0px; left: 0px; width: max-content; --popover-overflow-padding: 8px;"><div id="«r1o»" hidden="" data-dialog="" role="tooltip" tabindex="-1" data-placing="true" class="statements-table_tooltiptext quote_statements-tooltip z-10 is-ad" style="position: relative; display: none;"><div class="quote-statements-elite-tooltip"><div class="quote-statements-elite-tooltip_wrapper"><svg class="pointer-events-none block shrink-0 fill-current mx-auto text-blue-500" width="24" height="24"><use href="/assets/dist-icons/icons.svg?rev=26#lock"></use></svg><h2 class="quote-statements-elite-subscribe_title">Upgrade your FINVIZ experience</h2><p>Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features. Real-time quotes, advanced&nbsp;visualizations, historical statements, and much more.</p><a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=quote-statements" target="_blank" class="tab-link">Learn more</a></div></div></div></div></div></td><td align="right" class="align-top"><span class="">334.05</span></td><td align="right" class="align-top"><span class="">334.05</span></td><td align="right" class="align-top"><span class="">243.87</span></td></tr></tbody></table><table class="quote_statements-footer" width="100%" cellpadding="3"><tbody><tr><td align="right">values in Millions, USD</td></tr></tbody></table></div></td></tr><tr><td style="height:10px;font-size:0"><img src="gfx/nic2x2.gif" style="width:685px;height:10px" width="2" height="2"></td></tr>

            <tr><td>
                <script id="insider-init-data-0" type="application/json">[{"date":1721016000000,"saleAggregated":0,"saleTransactionCount":0,"buyAggregated":0,"buyTransactionCount":0},{"date":1723694400000,"saleAggregated":0,"saleTransactionCount":0,"buyAggregated":0,"buyTransactionCount":0},{"date":1726372800000,"saleAggregated":0,"saleTransactionCount":0,"buyAggregated":0,"buyTransactionCount":0},{"date":1728964800000,"saleAggregated":0,"saleTransactionCount":0,"buyAggregated":0,"buyTransactionCount":0},{"date":1731646800000,"saleAggregated":0,"saleTransactionCount":0,"buyAggregated":0,"buyTransactionCount":0},{"date":1734238800000,"saleAggregated":0,"saleTransactionCount":0,"buyAggregated":0,"buyTransactionCount":0},{"date":1736917200000,"saleAggregated":41920,"saleTransactionCount":2,"buyAggregated":0,"buyTransactionCount":0},{"date":1739595600000,"saleAggregated":0,"saleTransactionCount":0,"buyAggregated":0,"buyTransactionCount":0},{"date":1742011200000,"saleAggregated":119500,"saleTransactionCount":1,"buyAggregated":0,"buyTransactionCount":0},{"date":1744689600000,"saleAggregated":0,"saleTransactionCount":0,"buyAggregated":0,"buyTransactionCount":0},{"date":1747281600000,"saleAggregated":58200,"saleTransactionCount":2,"buyAggregated":0,"buyTransactionCount":0},{"date":1749960000000,"saleAggregated":533641.16,"saleTransactionCount":3,"buyAggregated":0,"buyTransactionCount":0},{"date":1752552000000,"saleAggregated":913692.6192999999,"saleTransactionCount":8,"buyAggregated":0,"buyTransactionCount":0}]</script>
                <div class="insider-trading-chart"><div class="my-6 border border-primary p-1 tabular-nums rounded-md"><div class="flex h-10 items-center"><span class="ml-2 mt-4 h-10 text-sm text-muted font-medium">Insider Trading Volume</span></div><div><div class="recharts-responsive-container" style="width: 100%; height: 300px; min-width: 0px;"><div class="recharts-wrapper" style="position: relative; cursor: default; width: 100%; height: 100%; max-height: 300px; max-width: 1054px;"><svg class="recharts-surface" width="1054" height="300" viewBox="0 0 1054 300" style="width: 100%; height: 100%;"><title></title><desc></desc><defs><clipPath id="recharts1-clip"><rect x="80" y="0" height="270" width="894"></rect></clipPath></defs><g class="recharts-cartesian-grid"><g class="recharts-cartesian-grid-horizontal"><line stroke="#ccc" stroke-dasharray="3 3" class="stroke-gray-100 dark:stroke-gray-700" fill="none" x="80" y="0" width="894" height="270" x1="80" y1="270" x2="974" y2="270"></line><line stroke="#ccc" stroke-dasharray="3 3" class="stroke-gray-100 dark:stroke-gray-700" fill="none" x="80" y="0" width="894" height="270" x1="80" y1="202.5" x2="974" y2="202.5"></line><line stroke="#ccc" stroke-dasharray="3 3" class="stroke-gray-100 dark:stroke-gray-700" fill="none" x="80" y="0" width="894" height="270" x1="80" y1="135" x2="974" y2="135"></line><line stroke="#ccc" stroke-dasharray="3 3" class="stroke-gray-100 dark:stroke-gray-700" fill="none" x="80" y="0" width="894" height="270" x1="80" y1="67.5" x2="974" y2="67.5"></line><line stroke="#ccc" stroke-dasharray="3 3" class="stroke-gray-100 dark:stroke-gray-700" fill="none" x="80" y="0" width="894" height="270" x1="80" y1="0" x2="974" y2="0"></line></g></g><g class="recharts-layer recharts-cartesian-axis recharts-xAxis xAxis fill-gray-500 dark:fill-gray-300"><g class="recharts-cartesian-axis-ticks"><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="112.35858680434515" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="112.35858680434515" dy="0.71em">Jul</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="182.34343733467304" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="182.34343733467304" dy="0.71em">Aug</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="252.32828786500096" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="252.32828786500096" dy="0.71em">Sep</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="320.0555625717699" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="320.0555625717699" dy="0.71em">Oct</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="390.1344787614127" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="390.1344787614127" dy="0.71em">Nov</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="457.8617534681816" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="457.8617534681816" dy="0.71em">Dec</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="527.8466039985096" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="527.8466039985096" dy="0.71em">25</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="597.8314545288374" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="597.8314545288374" dy="0.71em">Feb</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="660.9495119291734" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="660.9495119291734" dy="0.71em">Mar</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="730.9343624595014" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="730.9343624595014" dy="0.71em">Apr</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="798.6616371662702" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="798.6616371662702" dy="0.71em">May</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="868.6464876965981" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="868.6464876965981" dy="0.71em">Jun</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="bottom" width="894" height="30" stroke="none" font-size="10" font-weight="400" x="936.3737624033671" y="283" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="middle" fill=""><tspan x="936.3737624033671" dy="0.71em">Jul</tspan></text></g></g></g><g class="recharts-layer recharts-cartesian-axis recharts-yAxis yAxis fill-gray-500 dark:fill-gray-300"><g class="recharts-cartesian-axis-ticks"><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="right" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="982" y="270" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="start" fill=""><tspan x="982" dy="0.355em">0.00</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="right" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="982" y="202.5" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="start" fill=""><tspan x="982" dy="0.355em">250.00K</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="right" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="982" y="135" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="start" fill=""><tspan x="982" dy="0.355em">500.00K</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="right" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="982" y="67.5" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="start" fill=""><tspan x="982" dy="0.355em">750.00K</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="right" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="982" y="7.5" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="start" fill=""><tspan x="982" dy="0.355em">1.00M</tspan></text></g></g><text offset="5" content="[object Object]" font-size="10" font-weight="500" text-anchor="middle" dominant-baseline="central" class="stroke-bg-primary stroke-2 [paint-order:stroke_fill]" style="transform: translate(1042px, 135px) rotate(-90deg);"><tspan class="fill-gray-500 dark:fill-gray-300">USD Trades Volume</tspan></text></g><g class="recharts-layer recharts-cartesian-axis recharts-yAxis yAxis fill-gray-500 dark:fill-gray-300"><g class="recharts-cartesian-axis-ticks"><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="left" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="72" y="270" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="end" fill=""><tspan x="72" dy="0.355em">$4.00</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="left" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="72" y="202.5" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="end" fill=""><tspan x="72" dy="0.355em">$4.80</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="left" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="72" y="135.00000000000003" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="end" fill=""><tspan x="72" dy="0.355em">$5.60</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="left" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="72" y="67.49999999999997" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="end" fill=""><tspan x="72" dy="0.355em">$6.40</tspan></text></g><g class="recharts-layer recharts-cartesian-axis-tick"><text orientation="left" width="60" height="270" stroke="none" font-size="10" font-weight="500" x="72" y="7.5" class="recharts-text recharts-cartesian-axis-tick-value" text-anchor="end" fill=""><tspan x="72" dy="0.355em">$7.20</tspan></text></g></g><text offset="5" content="[object Object]" font-size="10" font-weight="500" text-anchor="middle" dominant-baseline="central" class="stroke-bg-primary stroke-2 [paint-order:stroke_fill]" style="transform: translate(12px, 135px) rotate(-90deg);"><tspan class="text-blue-400 fill-current">● </tspan><tspan class="fill-gray-500 dark:fill-gray-300">Close Price</tspan></text></g><g class="recharts-layer recharts-line fill-current stroke-current text-blue-400"><path width="894" height="270" stroke-width="1" fill="none" class="recharts-curve recharts-line-curve" d="M81.599,253.125L83.857,259.875L86.114,240.469L90.629,224.438L97.402,202.5L99.66,185.625L101.917,186.469L104.175,169.594L106.432,142.594L113.205,152.719L115.463,156.938L117.72,150.188L119.978,182.25L122.235,176.344L129.008,185.625L131.266,174.656L133.523,181.406L135.781,183.094L138.039,177.188L144.811,187.312L147.069,209.25L149.326,194.062L151.584,201.656L153.842,210.938L160.614,219.375L162.872,212.625L165.129,234.563L167.387,230.344L169.645,234.563L176.417,189.844L178.675,187.312L180.932,189.844L183.19,185.625L185.448,185.625L192.22,166.219L194.478,174.656L196.735,165.375L198.993,175.5L201.251,142.172L208.023,123.187L210.281,135L212.539,140.063L214.796,138.375L217.054,126.563L226.084,146.813L228.342,137.531L230.599,132.469L232.857,139.219L239.629,133.313L241.887,138.375L244.145,135.844L246.402,136.688L248.66,136.688L255.432,157.781L257.69,146.813L259.948,147.656L262.205,118.125L264.463,99.563L271.235,113.062L273.493,121.5L275.751,107.156L278.008,107.156L280.266,110.531L287.039,74.25L289.296,62.438L291.554,81.844L293.811,69.188L296.069,62.438L302.842,55.688L305.099,56.531L307.357,47.25L309.614,52.312L311.872,66.656L318.645,78.469L320.902,55.688L323.16,57.375L325.417,38.812L327.675,44.719L334.448,54.844L336.705,53.156L338.963,80.156L341.22,72.563L343.478,59.063L350.251,68.344L352.508,53.156L354.766,70.875L357.023,66.656L359.281,80.156L366.148,97.875L368.405,83.531L370.663,77.625L372.92,69.188L375.178,67.5L381.951,64.969L384.208,92.391L386.466,92.813L388.723,105.469L390.981,113.062L397.754,113.484L400.011,110.531L402.269,122.344L404.527,118.969L406.784,102.937L413.557,106.312L415.814,98.719L418.072,66.656L422.587,68.344L429.36,72.563L431.617,91.969L433.875,100.406L436.133,99.984L438.39,98.719L445.163,108L447.42,102.937L449.678,100.406L451.936,108.844L454.193,110.531L460.966,110.531L463.223,111.375L465.481,132.469L467.739,132.469L469.996,126.563L476.769,127.406L479.027,128.25L483.542,124.875L485.799,132.469L492.572,134.156L494.83,137.531L499.345,108.844L501.602,99.563L508.375,101.25L510.633,101.25L512.89,104.625L517.405,139.219L524.178,134.156L526.436,178.031L528.693,160.313L530.951,165.375L533.208,167.063L542.239,169.594L544.496,173.813L546.754,164.531L549.011,163.688L555.784,160.313L558.042,151.031L560.299,147.656L562.557,145.969L564.814,140.063L571.587,143.438L573.845,113.062L576.102,111.375L578.36,111.375L580.617,126.563L587.39,116.437L589.648,130.781L591.905,101.25L594.163,107.156L596.42,99.563L605.451,113.906L607.708,113.062L609.966,116.437L612.224,119.813L618.996,143.438L621.254,157.781L623.511,163.688L625.769,173.813L628.027,165.375L634.799,178.031L637.057,179.719L639.314,163.688L641.572,160.313L643.83,172.125L650.508,182.25L652.766,146.813L655.023,135.844L657.281,162L659.539,161.156L666.311,160.313L668.569,172.125L670.826,168.75L673.084,173.813L675.342,172.969L682.114,175.5L684.372,185.625L686.629,186.469L688.887,182.25L691.145,188.156L697.917,205.875L700.175,232.031L702.432,212.625L704.69,189.844L706.948,226.125L713.72,227.391L715.978,243L718.235,238.781L720.493,254.813L722.751,219.375L729.523,189.844L731.781,192.375L734.039,198.281L736.296,199.125L745.326,192.375L747.584,162L749.842,167.063L752.099,152.719L754.357,157.781L761.129,156.094L763.387,160.313L765.645,54L767.902,27.844L770.16,54L776.932,67.5L779.19,121.922L781.448,163.266L783.705,144.281L785.963,162.844L792.736,135L794.993,132.469L797.251,152.719L799.508,118.969L801.766,92.813L808.539,81.844L810.796,65.813L813.054,63.281L815.311,52.312L817.569,65.813L826.599,91.125L828.857,102.094L831.114,87.75L833.372,81L840.145,77.625L842.402,78.469L844.66,64.125L846.917,60.75L849.175,38.812L855.948,55.688L858.205,62.438L860.463,82.688L862.72,80.578L864.978,87.75L871.751,104.203L874.008,101.25L876.266,101.25L880.781,110.531L887.554,117.281L889.811,113.062L892.069,102.937L894.326,109.687L896.584,122.344L903.357,128.25L905.614,137.531L907.872,112.219L910.129,110.531L919.16,122.344L921.417,114.75L923.675,115.594L925.932,113.906L928.19,123.187L934.963,108L937.22,105.469L939.478,79.313L941.736,48.094L943.993,51.469L950.766,37.969L953.023,57.375L955.281,41.344L957.539,46.406L959.796,56.531L966.569,46.828"></path><g class="recharts-layer"></g></g><g class="recharts-layer recharts-bar"><g class="recharts-layer recharts-bar-rectangles"><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"><g><path x="496.28757529834166" y="0" width="60" height="270" radius="0" fill="transparent" class="recharts-rectangle" d="M 496.28757529834166,0 h 60 v 270 h -60 Z"></path><path x="522.2875752983416" y="258.6816" width="8" height="11.318399999999997" radius="2,2,0,0" class="recharts-rectangle fill-current text-red-400" d="M522.2875752983416,260.6816A 2,2,0,0,1,524.2875752983416,258.6816L 528.2875752983416,258.6816A 2,2,0,0,1,
        530.2875752983416,260.6816L 530.2875752983416,270L 522.2875752983416,270Z"></path></g></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"><g><path x="629.3904832290054" y="0" width="60" height="270" radius="0" fill="transparent" class="recharts-rectangle" d="M 629.3904832290054,0 h 60 v 270 h -60 Z"></path><path x="655.3904832290054" y="237.735" width="8" height="32.264999999999986" radius="2,2,0,0" class="recharts-rectangle fill-current text-red-400" d="M655.3904832290054,239.735A 2,2,0,0,1,657.3904832290054,237.735L 661.3904832290054,237.735A 2,2,0,0,1,
        663.3904832290054,239.735L 663.3904832290054,270L 655.3904832290054,270Z"></path></g></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"><g><path x="767.1026084661023" y="0" width="60" height="270" radius="0" fill="transparent" class="recharts-rectangle" d="M 767.1026084661023,0 h 60 v 270 h -60 Z"></path><path x="793.1026084661023" y="254.286" width="8" height="15.713999999999999" radius="2,2,0,0" class="recharts-rectangle fill-current text-red-400" d="M793.1026084661023,256.286A 2,2,0,0,1,795.1026084661023,254.286L 799.1026084661023,254.286A 2,2,0,0,1,
        801.1026084661023,256.286L 801.1026084661023,270L 793.1026084661023,270Z"></path></g></g><g class="recharts-layer recharts-bar-rectangle"><g><path x="837.0874589964301" y="0" width="60" height="270" radius="0" fill="transparent" class="recharts-rectangle" d="M 837.0874589964301,0 h 60 v 270 h -60 Z"></path><path x="863.0874589964301" y="125.91688679999999" width="8" height="144.0831132" radius="2,2,0,0" class="recharts-rectangle fill-current text-red-400" d="M863.0874589964301,127.91688679999999A 2,2,0,0,1,865.0874589964301,125.91688679999999L 869.0874589964301,125.91688679999999A 2,2,0,0,1,
        871.0874589964301,127.91688679999999L 871.0874589964301,270L 863.0874589964301,270Z"></path></g></g><g class="recharts-layer recharts-bar-rectangle"><g><path x="904.8147337031992" y="0" width="60" height="270" radius="0" fill="transparent" class="recharts-rectangle" d="M 904.8147337031992,0 h 60 v 270 h -60 Z"></path><path x="930.8147337031992" y="23.30299278900003" width="8" height="246.69700721099997" radius="2,2,0,0" class="recharts-rectangle fill-current text-red-400" d="M930.8147337031992,25.30299278900003A 2,2,0,0,1,932.8147337031992,23.30299278900003L 936.8147337031992,23.30299278900003A 2,2,0,0,1,
        938.8147337031992,25.30299278900003L 938.8147337031992,270L 930.8147337031992,270Z"></path></g></g></g><g class="recharts-layer"></g></g><g class="recharts-layer recharts-bar"><g class="recharts-layer recharts-bar-rectangles"><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g><g class="recharts-layer recharts-bar-rectangle"></g></g><g class="recharts-layer"></g></g></svg><div tabindex="-1" class="recharts-tooltip-wrapper recharts-tooltip-wrapper-right recharts-tooltip-wrapper-bottom" style="visibility: hidden; pointer-events: none; position: absolute; top: 0px; left: 0px; outline: none; z-index: 10; transform: translate(80px, 4px);"><div class="min-w-70 rounded-md border border-secondary bg-primary px-3.5 pb-2.5 pt-3.5 text-left font-sans text-2xs leading-4 text-muted-2 shadow-md opacity-0"><div class="grid grid-cols-[max-content,1fr,max-content] items-baseline gap-y-2"><div class=""></div><div class="label-with-bold-weight" data-text="Insider Sales Volume">Insider Sales Volume</div><div class="col-start-3 col-end-5 grid grid-cols-subgrid ml-2 text-right tabular-nums text-default"></div><div class=""></div><div class="label-with-bold-weight" data-text="Insider Buy Volume">Insider Buy Volume</div><div class="col-start-3 col-end-5 grid grid-cols-subgrid ml-2 text-right tabular-nums text-default"></div></div></div></div></div></div></div></div></div>
            </td></tr>
        <tr>
<td>
<table cellpadding="0" cellspacing="0" width="100%" class="body-table styled-table-new is-rounded p-0 mt-2">
<thead>
<tr>
<th class="" align="left">Insider Trading</th>
<th class="" align="left">Relationship</th>
<th class="" align="left">Date</th>
<th class="" align="center">Transaction</th>
<th class="" align="right">Cost</th>
<th class="" align="right">#Shares</th>
<th class="" align="right">Value ($)</th>
<th class="" align="right">#Shares Total</th>
<th class="" align="center">SEC Form 4</th>
</tr>
</thead>
<tbody><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1715291&amp;tc=7" class="tab-link">Vazzano Joseph Walter</a></td><td style="white-space:nowrap">Chief Financial Officer</td><td>Jul 22 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">6.64</td><td class="value" align="right">1,502</td><td class="value" align="right">9,975</td><td class="value" align="right">477,666</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225020575/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jul 22 04:15 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1715291&amp;tc=7" class="tab-link">Vazzano Joseph Walter</a></td><td style="white-space:nowrap">Officer</td><td>Jul 22 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">6.64</td><td class="value" align="right">1,502</td><td class="value" align="right">9,975</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000148/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jul 22 04:11 PM</a></td></tr><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1772546&amp;tc=7" class="tab-link">Silverstein Christine Berni</a></td><td style="white-space:nowrap">Director</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">13,093</td><td class="value" align="right">76,669</td><td class="value" align="right">120,479</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225018605/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jul 10 04:30 PM</a></td></tr><tr class="fv-insider-row is-sale-2" valign="top"><td><a href="insidertrading.ashx?oc=1865131&amp;tc=7" class="tab-link">Seshadri Vishwas</a></td><td style="white-space:nowrap">Chief Executive Officer</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">69,420</td><td class="value" align="right">406,503</td><td class="value" align="right">1,234,341</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225018606/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jul 10 04:30 PM</a></td></tr><tr class="fv-insider-row is-sale-2" valign="top"><td><a href="insidertrading.ashx?oc=1715291&amp;tc=7" class="tab-link">Vazzano Joseph Walter</a></td><td style="white-space:nowrap">Chief Financial Officer</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">25,411</td><td class="value" align="right">148,799</td><td class="value" align="right">479,168</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225018604/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jul 10 04:30 PM</a></td></tr><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1857854&amp;tc=7" class="tab-link">Wuchterl Donald A.</a></td><td style="white-space:nowrap">Director</td><td>Jul 08 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.82</td><td class="value" align="right">5,176</td><td class="value" align="right">30,147</td><td class="value" align="right">145,436</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225018603/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jul 10 04:30 PM</a></td></tr><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1853985&amp;tc=7" class="tab-link">Charles Faith L.</a></td><td style="white-space:nowrap">Director</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">10,738</td><td class="value" align="right">62,879</td><td class="value" align="right">139,094</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225018602/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jul 10 04:30 PM</a></td></tr><tr class="fv-insider-row is-sale-2" valign="top"><td><a href="insidertrading.ashx?oc=1884342&amp;tc=7" class="tab-link">O'Malley Brendan M.</a></td><td style="white-space:nowrap">SVP, Chief Legal Officer</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">17,428</td><td class="value" align="right">102,053</td><td class="value" align="right">360,817</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225018601/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jul 10 04:30 PM</a></td></tr><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Director</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">13,093</td><td class="value" align="right">76,669</td><td class="value" align="right">77,252</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225018599/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jul 10 04:30 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-2" valign="top"><td><a href="insidertrading.ashx?oc=1715291&amp;tc=7" class="tab-link">Vazzano Joseph Walter</a></td><td style="white-space:nowrap">Officer</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">25,335</td><td class="value" align="right">148,354</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000145/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jul 09 04:55 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-2" valign="top"><td><a href="insidertrading.ashx?oc=1865131&amp;tc=7" class="tab-link">Seshadri Vishwas</a></td><td style="white-space:nowrap">Officer</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">69,215</td><td class="value" align="right">405,302</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000144/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jul 09 04:52 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-2" valign="top"><td><a href="insidertrading.ashx?oc=1884342&amp;tc=7" class="tab-link">O'Malley Brendan M.</a></td><td style="white-space:nowrap">Officer</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">17,376</td><td class="value" align="right">101,749</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000143/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jul 09 04:48 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1853985&amp;tc=7" class="tab-link">Charles Faith L.</a></td><td style="white-space:nowrap">Director</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">10,706</td><td class="value" align="right">62,691</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000142/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jul 09 04:45 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1772546&amp;tc=7" class="tab-link">Silverstein Christine Berni</a></td><td style="white-space:nowrap">Director</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">13,054</td><td class="value" align="right">76,440</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000141/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jul 09 04:40 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Director</td><td>Jul 09 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.86</td><td class="value" align="right">13,054</td><td class="value" align="right">76,440</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000140/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jul 09 04:36 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1857854&amp;tc=7" class="tab-link">Wuchterl Donald A.</a></td><td style="white-space:nowrap">Director</td><td>Jul 08 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.82</td><td class="value" align="right">5,176</td><td class="value" align="right">30,147</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000138/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jul 08 04:06 PM</a></td></tr><tr class="fv-insider-row is-sale-2" valign="top"><td><a href="insidertrading.ashx?oc=1715291&amp;tc=7" class="tab-link">Vazzano Joseph Walter</a></td><td style="white-space:nowrap">Chief Financial Officer</td><td>Jun 06 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">6.76</td><td class="value" align="right">17,795</td><td class="value" align="right">120,294</td><td class="value" align="right">491,246</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225014178/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jun 06 06:04 PM</a></td></tr><tr class="fv-insider-row is-sale-2" valign="top"><td><a href="insidertrading.ashx?oc=1865131&amp;tc=7" class="tab-link">Seshadri Vishwas</a></td><td style="white-space:nowrap">Chief Executive Officer</td><td>Jun 06 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">6.76</td><td class="value" align="right">50,676</td><td class="value" align="right">342,570</td><td class="value" align="right">1,303,761</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225014172/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jun 06 06:00 PM</a></td></tr><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1884342&amp;tc=7" class="tab-link">O'Malley Brendan M.</a></td><td style="white-space:nowrap">SVP, General Counsel</td><td>Jun 06 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">6.76</td><td class="value" align="right">10,470</td><td class="value" align="right">70,777</td><td class="value" align="right">378,245</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225014167/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jun 06 05:56 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-2" valign="top"><td><a href="insidertrading.ashx?oc=1715291&amp;tc=7" class="tab-link">Vazzano Joseph Walter</a></td><td style="white-space:nowrap">Officer</td><td>Jun 06 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">6.76</td><td class="value" align="right">17,795</td><td class="value" align="right">120,314</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000120/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jun 06 04:13 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1884342&amp;tc=7" class="tab-link">O'Malley Brendan M.</a></td><td style="white-space:nowrap">Director</td><td>Jun 06 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">6.76</td><td class="value" align="right">10,470</td><td class="value" align="right">70,789</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000119/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jun 06 04:12 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-2" valign="top"><td><a href="insidertrading.ashx?oc=1865131&amp;tc=7" class="tab-link">Seshadri Vishwas</a></td><td style="white-space:nowrap">Officer</td><td>Jun 06 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">6.76</td><td class="value" align="right">50,676</td><td class="value" align="right">342,626</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000118/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jun 06 04:11 PM</a></td></tr><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Director</td><td>May 27 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">6.38</td><td class="value" align="right">2,000</td><td class="value" align="right">12,760</td><td class="value" align="right">90,435</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225012556/xslF345X05/ownership.xml" class="tab-link" target="_blank">May 27 07:57 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Director</td><td>May 27 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">6.38</td><td class="value" align="right">2,000</td><td class="value" align="right">12,762</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000101/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">May 27 04:40 PM</a></td></tr><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Director</td><td>May 16 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.68</td><td class="value" align="right">8,000</td><td class="value" align="right">45,440</td><td class="value" align="right">92,435</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225011289/xslF345X05/ownership.xml" class="tab-link" target="_blank">May 16 05:23 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Director</td><td>May 16 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.68</td><td class="value" align="right">8,000</td><td class="value" align="right">45,423</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000093/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">May 16 04:07 PM</a></td></tr><tr class="fv-insider-row is-sale-2" valign="top"><td><a href="insidertrading.ashx?oc=1865131&amp;tc=7" class="tab-link">Seshadri Vishwas</a></td><td style="white-space:nowrap">Chief Executive Officer</td><td>Mar 31 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">4.78</td><td class="value" align="right">25,000</td><td class="value" align="right">119,500</td><td class="value" align="right">1,355,322</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000164117225001922/xslF345X05/ownership.xml" class="tab-link" target="_blank">Mar 31 07:17 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-2" valign="top"><td><a href="insidertrading.ashx?oc=1865131&amp;tc=7" class="tab-link">Seshadri Vishwas</a></td><td style="white-space:nowrap">Officer</td><td>Mar 31 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">4.78</td><td class="value" align="right">25,000</td><td class="value" align="right">119,560</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000063/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Mar 31 04:08 PM</a></td></tr><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Director</td><td>Jan 29 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.38</td><td class="value" align="right">4,000</td><td class="value" align="right">21,520</td><td class="value" align="right">64,334</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000149315225004437/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jan 31 04:30 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Officer</td><td>Jan 29 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.41</td><td class="value" align="right">4,000</td><td class="value" align="right">21,640</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000018/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jan 29 04:03 PM</a></td></tr><tr class="fv-insider-row is-sale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Director</td><td>Jan 21 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Sale</span></td><td class="value" align="right">5.10</td><td class="value" align="right">4,000</td><td class="value" align="right">20,400</td><td class="value" align="right">68,334</td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000149315225003052/xslF345X05/ownership.xml" class="tab-link" target="_blank">Jan 21 04:30 PM</a></td></tr><tr class="fv-insider-row is-proposedSale-1" valign="top"><td><a href="insidertrading.ashx?oc=1356828&amp;tc=7" class="tab-link">Alvino Mark</a></td><td style="white-space:nowrap">Officer</td><td>Jan 21 '25</td><td class="transaction" style="white-space:nowrap" align="center"><span>Proposed Sale</span></td><td class="value" align="right">5.22</td><td class="value" align="right">4,000</td><td class="value" align="right">20,880</td><td class="value" align="right"></td><td class="whitespace-nowrap tabular-nums" align="center"><a href="http://www.sec.gov/Archives/edgar/data/318306/000197248125000014/xsl144X01/primary_doc.xml" class="tab-link" target="_blank">Jan 21 04:05 PM</a></td></tr></tbody></table>
</td>
</tr>
</tbody></table><table style="margin: 21px auto 14px auto" cellpadding="0" cellspacing="0" border="0">
<tbody><tr class="flex">
<td class="fullview-links flex items-center" align="left" valign="center">
<a target="_blank" class="tab-link" href="https://finance.yahoo.com/quote/ABEO" rel="nofollow" onclick="window.gtag &amp;&amp; window.gtag('event', 'click', { event_category: 'fvlinksQuote', event_label: 'yahoo' });">open in yahoo</a>&nbsp;|&nbsp;<a target="_blank" class="tab-link" href="https://www.reuters.com/companies/ABEO.OQ" rel="nofollow" onclick="window.gtag &amp;&amp; window.gtag('event', 'click', { event_category: 'fvlinksQuote', event_label: 'reuters' });">open in reuters</a>&nbsp;|&nbsp;<a target="_blank" class="tab-link" href="https://www.marketwatch.com/investing/stock/abeo" rel="nofollow" onclick="window.gtag &amp;&amp; window.gtag('event', 'click', { event_category: 'fvlinksQuote', event_label: 'marketwatch' });">open in marketwatch</a>&nbsp;|&nbsp;<a target="_blank" class="tab-link" href="https://www.google.com/finance/quote/ABEO:NASDAQ" rel="nofollow" onclick="window.gtag &amp;&amp; window.gtag('event', 'click', { event_category: 'fvlinksQuote', event_label: 'google' });">open in google</a>&nbsp;|&nbsp;<a target="_blank" class="tab-link" href="https://www.sec.gov/edgar/browse/?CIK=318306" rel="nofollow" onclick="window.gtag &amp;&amp; window.gtag('event', 'click', { event_category: 'fvlinksQuote', event_label: 'edgar' });">open in EDGAR</a></td>
</tr>
</tbody></table>
</div></td></tr></tbody></table>


</div>
</div>
</div><div class="my-3"><div id="IC_D_3x3_1" class="relative overflow-hidden flex items-center justify-center w-full mx-auto" style="width:970px;height:250px;max-height:250px"></div></div>
            <div class="footer" style="margin-top: 20px;padding-bottom: 215px">
                <div class="footer_links">
                    <a class="tab-link" href="/affiliate.ashx">Affiliate</a>
                    <span class="footer_dot"> • </span>
                    <a class="tab-link" href="/advertise.ashx">Advertise</a>
                    
                    <span class="footer_dot"> • </span><a class="tab-link" href="/theme">Theme Settings</a>
                    <span class="footer_dot"> • </span>
                    <a class="tab-link" href="/contact.ashx">Contact</a>
                    <span class="footer_dot"> • </span>
                    <a class="tab-link" href="/blog">Blog</a>
                    <span class="footer_dot"> • </span>
                    <a class="tab-link" href="/help/screener.ashx">Help</a>
                    <span class="footer_dot"> • </span>
                    <a class="tab-link" href="/privacy.ashx">Privacy</a><span class="footer_dot"> • </span> <a id="ic_us_privacy" class="tab-link relative overflow-hidden [&amp;>a]:absolute [&amp;>a]:inset-0 [&amp;>a]:-indent-[9999em]" href="#">Do Not Sell My Personal Information</a>    </div>
    Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
    <br>
    Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.
    
</div><script>SearchFocus();</script><script src="/assets/dist/2898.9cc956ed.js" onerror="window.handleScriptNotLoaded(this)"></script><iframe name="__tcfapiLocator" style="display: none;"></iframe><iframe name="__gppLocator" style="display: none;"></iframe><script src="/assets/dist/954.df9c9dea.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/6153.181fd929.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/6369.d628b086.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/7470.8715c862.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/1545.f2265a6f.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/5747.e0a24ab5.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/1213.58b9b5ca.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/4841.f74a7ed9.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/5762.39085d07.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/6019.f36d0e38.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/505.c5aac46e.js" onerror="window.handleScriptNotLoaded(this)"></script><script src="/assets/dist/main.7612593a.js" onerror="window.handleScriptNotLoaded(this)"></script><link rel="preload" as="script" href="/assets/dist/recent_quotes.4b44172f.js" data-chunk-id="recent_quotes"><script>
            function FinvizReady(fn) {
              if (document.readyState != 'loading'){
                fn();
              } else {
                document.addEventListener('DOMContentLoaded', fn);
              }
            }

            (typeof StocktwitsInit === 'function' && FinvizReady(StocktwitsInit));
            (typeof FinvizSettings === 'object' && (FinvizSettings.quoteSearchExt = '&ty=c&ta=1&p=d'));
        </script>
        <div id="js-set-search-ext-argument" class="hidden" data-set-search-ext-argument="&amp;ty=c&amp;ta=1&amp;p=d"></div>
            <script>
                window.dataLayer = window.dataLayer || [];
            </script>
            <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
            new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
            j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
            'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
            })(window,document,'script','dataLayer','GTM-537M973G');</script>
            <script>
              function getSystemTheme() {
                if (window.matchMedia && window.matchMedia('(prefers-color-scheme: dark)').matches) {
                  return 'Dark';
                }
                else if (window.matchMedia && window.matchMedia('(prefers-color-scheme: light)').matches) {
                  return 'Light';
                }
                return 'No Preference';
              }

              var systemTheme = getSystemTheme()

              const headlessChrome = navigator.userAgent.includes('HeadlessChrome')
              const webdriver = navigator.webdriver

              let cdp = false
              try {
                let accessed = false
                const e = new window.Error('ignore')
                window.Object.defineProperty(e, 'stack', {
                  configurable: false,
                  enumerable: false,
                  get: function () {
                    accessed = true
                    return ''
                  },
                })
                // This is part of the detection and shouldn't be deleted
                window.console.debug(e)
                cdp = accessed
              } catch {}

              window.dataLayer = window.dataLayer || [];
              function gtag(){dataLayer.push(arguments);}
              gtag('js', new Date());

              var fGaM = {
                'dimension1': 'NotLoggedIn',
                'dimension3': window.devicePixelRatio,
                'layoutTheme': 'dark',
                'systemTheme': systemTheme,
                'bundle': 'modern',
                'prefTheme': 'dark',
                'themeFlag': 'modern',
                innerWidth: window.innerWidth,
                innerHeight: window.innerHeight,
                webdriver: webdriver,
                cdp: cdp,
                isBot: headlessChrome || webdriver || cdp,
                icAdsVariant: 'control',
              };

              gtag('config', 'G-ZT9VQEWD4N', fGaM);
              
            </script>
            <script type="text/javascript">
        window._qevents = window._qevents || [];

        (function() {
            var elem = document.createElement('script');
            elem.src = (document.location.protocol == "https:" ? "https://secure" : "http://edge") + ".quantserve.com/quant.js";
            elem.async = true;
            elem.type = "text/javascript";
            var scpt = document.getElementsByTagName('script')[0];
            scpt.parentNode.insertBefore(elem, scpt);
        })();

        window._qevents.push({
            qacct:"p-c2W8esUZ6Q8oA"
        });
    </script>
    <noscript>
        <div style="display:none;">
            <img src="//pixel.quantserve.com/pixel/p-c2W8esUZ6Q8oA.gif" border="0" height="1" width="1" alt="Quantcast"/>
        </div>
    </noscript><div id="IC_D_1x1_1" class="relative overflow-hidden flex items-center justify-center w-full mx-auto"></div><div id="modal-elite-ad" class="modal-elite-ad">
                            <div id="modal-elite-ad_content" class="modal-elite-ad_content">
			                    <button id="modal-elite-ad-close" type="button" class="modal-elite-ad_close">×</button>

                                <!--<div id="modal-elite-ad-content-0" style="display: none">
			                        <h2>Ever heard of Finviz*Elite?</h2>
                                    <p>
                                        Our premium service offers you real-time quotes, advanced visualizations, technical studies, and much more.<br>
                                        Become Elite and make informed financial decisions.
                                    </p>
                                    <a href="/elite?utm_source=finviz&utm_medium=banner&utm_campaign=modal-0" id="modal-elite-ad-btn-0" class="" target="_blank">Find out more</a>
                                </div>-->

                                <div id="modal-elite-ad-content-1" style="display: block">
			                        <h2>Upgrade your FINVIZ experience</h2>
                                    <p>
                                        Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features.
                                        Real-time quotes, advanced&nbsp;visualizations, backtesting, and much more.
                                    </p>
                                    <a href="/elite?utm_source=finviz&amp;utm_medium=banner&amp;utm_campaign=modal-1" id="modal-elite-ad-btn-1" class="modal-elite_button" target="_blank">Learn more about FINVIZ*Elite</a>
                                </div>
                            </div>
                         </div><script src="/assets/dist/script/pv.27fa030f.js" async=""></script><script defer="">window.renderScriptNotLoaded();</script>
<script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;9665c8cf1a6b2315&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.7.0&quot;,&quot;token&quot;:&quot;e53f08f6c9e04bfd9760701085ec93b4&quot;}" crossorigin="anonymous"></script>


<span id="recharts_measurement_span" aria-hidden="true" style="position: absolute; top: -20000px; left: 0px; padding: 0px; margin: 0px; border: none; white-space: pre; font-size: 10px; letter-spacing: normal;">$4.00</span><img src="https://static.adsafeprotected.com/skeleton.gif?adspot_id=ryghhm_728x90_" decoding="async" width="1" height="1" style="width: 336px !important; height: 974px !important; position: fixed !important; left: -346px !important; top: -984px !important; display: block;"><script async="true" src="//api.stocktwits.com/addon/widget/2/widget-loader.min.js"></script><div style="position: absolute; visibility: hidden; z-index: 10010; transform: translate3d(0px, 0px, 0px);"><div></div><div></div></div><iframe src="javascript:false;" frameborder="0" scrolling="no" style="visibility: hidden; opacity: 0; left: 0px; top: 0px; width: 0px; height: 0px; position: absolute; z-index: 10;"></iframe><iframe id="ICUid_Iframe" src="https://uat5-a.investingchannel.com/start.html" style="display: none;"></iframe><iframe height="0" width="0" style="display: none; visibility: hidden;"></iframe><iframe id="IC_PM_Uid_Iframe" width="1" height="1" src="https://ads.pubmatic.com/AdServer/js/user_sync.html?p=52041&amp;&amp;predirect=https%3A%2F%2Fuat5-a.investingchannel.com%2Fuser%2Fsync%2Fpubmatic%3Fpubmaticuid%3DPM_UID%26ord%3D0e1dc69e-e937-4b7e-ad6c-1c5d1ef59684%26gdprapplicable%3Dfalse%26uspstatus%3DNOT_APPLICABLE&amp;userIdMacro=PM_UID" style="display: none;"></iframe></body></html>